Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1050.Time spend outdoors in summer,46329,0.0419089187108336,0.0200940879868218,0.00252450625666282,0.0812933311650044,0.0370172237937312
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1060.Time spent outdoors in winter,40403,-0.0340723009639534,0.0225814242818449,-0.0783318925563695,0.0101872906284627,0.131341332006925
CD300E,CMRF35-like molecule 2,Physical activities,X1070.Time spent watching television (TV),48726,0.248446191538895,0.0202943932378637,0.208669180792682,0.288223202285108,2.08048197990071e-34
CD300E,CMRF35-like molecule 2,Physical activities,X1080.Time spent using computer,40442,-0.0881378865893398,0.0204524491879044,-0.128224686997632,-0.0480510861810472,1.64080717130056e-05
CD300E,CMRF35-like molecule 2,Physical activities,X1090.Time spent driving,35074,-0.142736302544716,0.0224458824334888,-0.186730232114354,-0.0987423729750774,2.05393685821906e-10
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1160.Sleep duration,51340,0.0625427193852023,0.0182399336250361,0.0267924494801314,0.0982929892902731,0.000606531806559442
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17182,0.00244002653003675,0.0107417114214449,-0.0186137278559953,0.0234937809160688,0.820306424055864
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17182,0.00228143550196653,0.0104805010704624,-0.0182603465961397,0.0228232176000728,0.827678058662426
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17182,0.00933507689694913,0.0119461140712444,-0.0140793066826898,0.0327494604765881,0.434559178674045
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17182,0.0206703135252442,0.0122280487328687,-0.00329666199117849,0.0446372890416668,0.0909692967294562
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17182,0.028455309167828,0.012437717238907,0.00407738337957026,0.0528332349560857,0.0221598680015928
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17182,0.0104177631286649,0.0265633497027083,-0.0416464022886434,0.0624819285459731,0.694925954652369
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17182,0.0526033920804991,0.0275830881147388,-0.00145946062438885,0.106666244785387,0.0565257920144827
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17182,0.0174674153926695,0.0188304008907322,-0.0194401703531656,0.0543750011385046,0.353618892168789
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17182,0.0235852842900319,0.0138134105150615,-0.00348900031948871,0.0506595688995525,0.0877622186477906
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17182,0.0130879579402571,0.00946794354405632,-0.00546921140609327,0.0316451272866075,0.166883987620668
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17182,0.0352688503562306,0.0137007699976946,0.00841534116074919,0.0621223595517121,0.0100548253438857
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17182,0.00102059926326191,0.00767996475124555,-0.0140321316491794,0.0160733301757032,0.894281032277408
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17182,-0.00159310610687271,0.00992416525450347,-0.0210444700056995,0.0178582577919541,0.872467078772933
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17182,0.0132342945792178,0.0146817595010967,-0.0155419540429318,0.0420105432013673,0.367382658726521
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17182,0.0174724362723647,0.0138777532487845,-0.00972796009525293,0.0446728326399824,0.208038472840981
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17182,0.0484019344367689,0.01855709805865,0.0120300222418149,0.0847738466317229,0.00910797791367149
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17182,0.0275839468864699,0.017515916528914,-0.00674724951020152,0.0619151432831414,0.115322604266082
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17182,0.0146882766404554,0.0107644060902972,-0.00640995929652721,0.035786512577438,0.172420994285347
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17182,0.014579559602409,0.0102049801790046,-0.00542220154844001,0.0345813207532581,0.153116999193619
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17182,0.0168495288236639,0.0127445597140493,-0.00812980821587279,0.0418288658632006,0.186153867659002
CD300E,CMRF35-like molecule 2,Health and medical history,X120040.Fatigue severity over the past week,17194,0.190498420606459,0.0341943808007371,0.123477434237014,0.257519406975904,2.57015876341652e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,17194,0.156790649949095,0.0339450876481052,0.0902582781588092,0.223323021739381,3.88485666179844e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,17194,0.102722075338583,0.0366931746745843,0.0308034529763979,0.174640697700768,0.00512409304665943
CD300E,CMRF35-like molecule 2,Health and medical history,X120098.Mobility problems today,17203,0.313915493431741,0.0398201721534694,0.235867956010941,0.391963030852541,3.37755298044729e-15
CD300E,CMRF35-like molecule 2,Health and medical history,X120099.Self-care problems today,17203,0.222087353995811,0.0608308991677815,0.102858791626959,0.341315916364663,0.00026210106203111
CD300E,CMRF35-like molecule 2,Health and medical history,X120100.Problems doing usual activities,17203,0.224050473192272,0.0380692583556979,0.149434726815104,0.29866621956944,4.0462651026186e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X120101.Pain or discomfort today,17203,0.0963158127429108,0.0342122258037404,0.0292598501675795,0.163371775318242,0.00487954502694211
CD300E,CMRF35-like molecule 2,Health and medical history,X120102.Anxiety or depression today,17203,0.0816418659728821,0.0413156743900043,0.000663144168473642,0.162620587777291,0.0481650058442241
CD300E,CMRF35-like molecule 2,Health and medical history,X120103.Scale to indicate how health is today,17145,-0.0196945864957971,0.00332538254533373,-0.0262123362846512,-0.0131768367069429,3.23142009606456e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17162,0.163473919148481,0.041675712687671,0.0817895222806463,0.245158316016316,8.79681380892746e-05
CD300E,CMRF35-like molecule 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17137,0.0603507771832039,0.0429745751447455,-0.0238793901004973,0.144580944466905,0.160236722038935
CD300E,CMRF35-like molecule 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17173,0.0859016071921735,0.0339313501860167,0.0193961608275808,0.152407053556766,0.0113622384295108
CD300E,CMRF35-like molecule 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17173,0.178969945831758,0.0348697986989521,0.110625140381812,0.247314751281704,2.89008923975356e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17180,0.22851666107816,0.0447574505930351,0.140792057915811,0.316241264240509,3.3315326553225e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,17132,0.0753689631044201,0.045108722425791,-0.0130441328501303,0.163782059058971,0.0947737344930689
CD300E,CMRF35-like molecule 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,17178,0.10411752305557,0.0450855389297121,0.0157498667533345,0.192485179357806,0.0209369235668005
CD300E,CMRF35-like molecule 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17161,0.244769398295558,0.0647979345045173,0.117765446666704,0.371773349924412,0.00015899313650969
CD300E,CMRF35-like molecule 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17090,0.184113613291765,0.0886116151799862,0.0104348475389917,0.357792379044538,0.0377464351279372
CD300E,CMRF35-like molecule 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11969,0.218278429408567,0.0456067685040884,0.128889163140553,0.30766769567658,1.72091855108922e-06
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46443,0.148666430478097,0.0429268448950665,0.0645298144837666,0.232803046472427,0.000534171470344406
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43348,0.0475532968995055,0.0267518039423347,-0.00488023882747045,0.0999868326264814,0.0754809463570749
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1289.Cooked vegetable intake,49862,-0.163141870581632,0.0189415164954929,-0.200267242912799,-0.126016498250466,7.32645023178578e-18
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48501,-0.161548190305047,0.0200294263933988,-0.200805866036109,-0.122290514573985,7.45679515162686e-16
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1309.Fresh fruit intake,49754,-0.122710912640304,0.0199119381249712,-0.161738311365248,-0.0836835139153606,7.20710787241311e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1319.Dried fruit intake,47003,-0.170953523432336,0.0205460627364825,-0.211223806395842,-0.130683240468831,8.99185935237315e-17
CD300E,CMRF35-like molecule 2,Health and medical history,X134.Number of self-reported cancers,51775,0.226160586869348,0.034104003379706,0.159316740245124,0.293004433493572,3.35557894610923e-11
CD300E,CMRF35-like molecule 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51776,0.308981881771558,0.0192176677097882,0.271315253060373,0.346648510482743,5.03190846586266e-58
CD300E,CMRF35-like molecule 2,Health and medical history,"X136.Number of operations, self-reported",51776,0.181502853907888,0.0187388173552309,0.144774771891635,0.218230935924141,3.61383081866382e-22
CD300E,CMRF35-like molecule 2,Health and medical history,X137.Number of treatments or medications taken,51776,0.325607275241173,0.0187989203401292,0.28876139137452,0.362453159107826,5.09228161257567e-67
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1438.Bread intake,50263,0.0146192017487058,0.00212388403895538,0.0104563890323532,0.0187820144650583,5.91909826108834e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1458.Cereal intake,49160,0.0986872919276322,0.0188745955838701,0.0616930845832468,0.135681499272018,1.71516361941331e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1488.Tea intake,49963,0.0128542077571204,0.00203022829666303,0.00887496029566086,0.0168334552185799,2.44988777342354e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1498.Coffee intake,47730,-0.256618329897616,0.0189981748603867,-0.293854752623974,-0.219381907171258,1.68337032729321e-41
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1528.Water intake,47857,-0.0650190410032796,0.019205363288381,-0.102661553048506,-0.0273765289580528,0.000711154565824847
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1568.Average weekly red wine intake,35228,-0.323473452107284,0.0225110307066677,-0.367595072292352,-0.279351831922215,1.08940702752166e-46
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35220,-0.16897239073388,0.0230876538746501,-0.214224192328194,-0.123720589139566,2.5566158261263e-13
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,35317,0.0298214452617908,0.0254185078431821,-0.0199988301108462,0.0796417206344278,0.240716400788948
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1598.Average weekly spirits intake,35175,0.0283408123300331,0.0245547652220827,-0.019786527505249,0.0764681521653152,0.24843099676521
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1608.Average weekly fortified wine intake,35295,-0.0559097075210484,0.040575141152061,-0.135436984179088,0.0236175691369911,0.168233615967331
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1737.Childhood sunburn occasions,38839,-0.110183582153088,0.0226199755362274,-0.154518734204094,-0.0658484301020827,1.11429516733711e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X1807.Father's age at death,38127,-0.00963739796077457,0.00237525762076701,-0.0142929028974779,-0.00498189302407123,4.97183568564113e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X1845.Mother's age,19691,-0.0184153840678915,0.00515523954077257,-0.0285196535678057,-0.00831111456797723,0.00035488270469536
CD300E,CMRF35-like molecule 2,Health and medical history,X1873.Number of full brothers,50847,0.014366622840709,0.0181853906861327,-0.021276742904111,0.0500099885855291,0.429526180486557
CD300E,CMRF35-like molecule 2,Health and medical history,X1883.Number of full sisters,50856,0.0316622856383524,0.0182424617138273,-0.00409293932074919,0.067417510597454,0.08263415532079
CD300E,CMRF35-like molecule 2,Physical measures,X20015.Sitting height,51370,-0.000459509672507275,0.00267321835866304,-0.00569901765548683,0.00477999831047228,0.863521695096719
CD300E,CMRF35-like molecule 2,Cognitive function,X20016.Fluid intelligence score,16602,-0.149599272124948,0.0306027070385042,-0.209580577920417,-0.08961796632948,1.02593023016472e-06
CD300E,CMRF35-like molecule 2,Cognitive function,X20018.Prospective memory result,17295,0.115301025242002,0.0395990571512208,0.0376868732256092,0.192915177258395,0.00359914182517441
CD300E,CMRF35-like molecule 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16384,0.0132604702054699,0.00365326360929317,0.0061000735312553,0.0204208668796845,0.000284549250715805
CD300E,CMRF35-like molecule 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16359,0.0132904611141756,0.0036447865019097,0.00614667957043256,0.0204342426579186,0.000266733784335923
CD300E,CMRF35-like molecule 2,Cognitive function,X20023.Mean time to correctly identify matches,51153,0.0169631264379505,0.00214888436506079,0.0127513130824314,0.0211749397934697,2.98622048428153e-15
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45032,0.00450021040043628,0.00455245682102141,-0.00442260496876569,0.0134230257696382,0.322901660207121
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44150,-0.0158028094189739,0.010035544037586,-0.0354724757326425,0.00386685689469461,0.11533659808996
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44079,-0.0129027904658412,0.0134011834661442,-0.0391691100594839,0.0133635291278015,0.335648276656893
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44121,-0.00668766270408791,0.011337041625435,-0.0289082642899404,0.0155329388817646,0.555264154930556
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44144,-0.00650923938320195,0.00809284291328932,-0.022371211493249,0.00935273272684511,0.421216239494705
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#2.Illnesses of father_Stroke,44490,-0.0040935423262022,0.00585892499117614,-0.0155770353089074,0.00738995065650304,0.484752636085676
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44368,0.00716010843928327,0.00738403409102052,-0.00731259837911694,0.0216328152576835,0.332214128537496
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44169,-0.0114561799433494,0.0092221636091464,-0.0295316206172763,0.00661926073057757,0.214153046295743
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44451,0.0233343353680962,0.00677492647417065,0.0100554794787217,0.0366131912574707,0.000573238209537886
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44597,0.00147883002538969,0.00509349529262491,-0.00850442074815513,0.0114620807989345,0.771559803390203
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44322,0.00693687119646232,0.00705235846897292,-0.0068857514027246,0.0207594937956492,0.325305641224131
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47229,0.0175048399483775,0.00522804017962243,0.00725788119631757,0.0277517987004375,0.000813841033074051
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46931,-0.0219104946454149,0.00749517667295441,-0.0366010409244055,-0.00721994836642422,0.00346531133400724
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46785,0.00403642691096327,0.0162678102913575,-0.0278484812600975,0.035921335082024,0.804039900918939
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46858,0.00452902513666267,0.00839310852708083,-0.0119214675764157,0.0209795178497411,0.589466952761244
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,47103,0.014358119314052,0.00595093514126655,0.00269428643716957,0.0260219521909344,0.0158364667060025
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46886,0.0156320191420989,0.0105152483078487,-0.00497786754128458,0.0362419058254824,0.137125932102948
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46847,-0.0154920377182966,0.00944489082560019,-0.034004023736473,0.00301994829987972,0.10095869061917
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46885,-0.00739841846281921,0.00766789627235034,-0.0224274951566259,0.00763065823098745,0.33462174160159
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46937,0.0533408290000487,0.00882883246684321,0.036036317365036,0.0706453406350614,1.53679109457083e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47303,0.00121802389008356,0.00452324914188673,-0.00764754442801442,0.0100835922081815,0.787714824692224
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46999,0.0169310707813537,0.00697518350144785,0.00325971111851586,0.0306024304441914,0.0152141542351907
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40511,0.0132806160161861,0.00730348762534048,-0.0010342197294812,0.0275954517618535,0.0690113614396027
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40218,0.0334113106727413,0.0289486135429652,-0.0233279718714704,0.090150593216953,0.248441738153065
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40207,-0.0109302551882454,0.0293621904045765,-0.0684801483812153,0.0466196380047244,0.709704125591493
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40326,-0.00436091552844397,0.00860646400251995,-0.0212295849733831,0.0125077539164951,0.612366453351619
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40239,0.00948514889719065,0.0170029347910906,-0.0238406032933469,0.0428109010877282,0.576947442069231
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40287,0.0211087914929406,0.0123438633752246,-0.00308518072249965,0.0453027637083809,0.0872618146665224
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40239,0.0396804974667253,0.0146087540222857,0.0110473395830453,0.0683136553504053,0.00660614976248826
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40242,0.0179058385506235,0.0141760618918453,-0.00987924275739326,0.0456909198586402,0.206559176306568
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40267,-0.000973459990073313,0.0107426634293297,-0.0220290803115596,0.0200821603314129,0.927797961783732
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40286,0.032872011239977,0.013248973351117,0.00690402347178766,0.0588399990081664,0.0131018583535288
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40648,0.00223273812765639,0.00545826693969462,-0.00846546507414506,0.0129309413294578,0.682500548204871
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40429,0.0266399629298366,0.00773666017871789,0.0114761089795496,0.0418038168801237,0.000575155355835481
CD300E,CMRF35-like molecule 2,Mental health,X20127.Neuroticism score,41155,0.0873635833591533,0.0191013990233498,0.0499248412733876,0.124802325444919,4.80639989883205e-06
CD300E,CMRF35-like molecule 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16602,-0.0340374491096311,0.0310494899574922,-0.0948944494263158,0.0268195512070537,0.272993118811048
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20161.Pack years of smoking,15770,0.036639232777082,0.00397449504899815,0.0288492224810456,0.0444292430731184,3.38353749060028e-20
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15770,0.0359168739392262,0.00392036017070158,0.0282329680046511,0.0436007798738013,5.72959134133223e-20
CD300E,CMRF35-like molecule 2,Cognitive function,X20191.Fluid intelligence score,12784,-0.0267949119782498,0.0359283043391345,-0.0972143884829534,0.0436245645264537,0.45580899919354
CD300E,CMRF35-like molecule 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12785,-0.0358752988165421,0.0367181281334806,-0.107842829958164,0.0360922323250799,0.328564922771555
CD300E,CMRF35-like molecule 2,Cognitive function,X20240.Maximum digits remembered correctly,11484,-0.0974618067871261,0.0385334177158012,-0.172987305510096,-0.0219363080641557,0.0114429705039355
CD300E,CMRF35-like molecule 2,Physical measures,X20255.Spirometry QC measure,38514,-0.0103990927713486,0.0247153616636717,-0.058841201632145,0.0380430160894479,0.673936911018449
CD300E,CMRF35-like molecule 2,Eye measures,X20261.avMSE,11312,0.0114192932164956,0.00428490397983913,0.00302088141601086,0.0198177050169802,0.00770964510306506
CD300E,CMRF35-like molecule 2,Eye measures,X20262.Myopia diagnosis,11312,-0.0549795644714198,0.0470569122628069,-0.147211112506521,0.0372519835636818,0.242684948491974
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20280.Glucose-lactate,29570,-0.00720209951105089,0.00273871132579543,-0.0125699737096099,-0.00183422531249185,0.0085494377709965
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,29632,-0.014826708677046,0.00274975183811659,-0.0202162222797545,-0.00943719507433743,7.02036889311151e-08
CD300E,CMRF35-like molecule 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16154,-0.0383452155675548,0.0145244452751403,-0.0668131283068298,-0.00987730282827968,0.00829743084414968
CD300E,CMRF35-like molecule 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16151,-0.0100579734291601,0.0286073258657286,-0.0661283321259882,0.0460123852676679,0.725152356121219
CD300E,CMRF35-like molecule 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16149,-0.0459788017694068,0.035288146348916,-0.115143568613282,0.0231859650744686,0.192609347710235
CD300E,CMRF35-like molecule 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16149,-0.0411747050611832,0.0137901218206472,-0.0682033438296517,-0.0141460662927148,0.00283251256253167
CD300E,CMRF35-like molecule 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16149,-0.0740018490765801,0.0239868560495504,-0.121016086933699,-0.0269876112194613,0.00203827881205914
CD300E,CMRF35-like molecule 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16159,-0.0291776779273216,0.0306009703207463,-0.0891555797559844,0.0308002239013413,0.340356818239152
CD300E,CMRF35-like molecule 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16159,-0.0180606572668786,0.0198956556923337,-0.0570561424238527,0.0209348278900954,0.364013887589148
CD300E,CMRF35-like molecule 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16159,-0.00251137587779246,0.022317530529664,-0.0462537357159339,0.0412309839603489,0.910405145717467
CD300E,CMRF35-like molecule 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16159,0.0229931629854785,0.0345763289559012,-0.0447764417680878,0.0907627677390448,0.506061763314631
CD300E,CMRF35-like molecule 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16159,0.0266430135371072,0.040254960124635,-0.0522567083071774,0.105542735381392,0.508072534609894
CD300E,CMRF35-like molecule 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16159,0.00836122006827724,0.0233823934917961,-0.0374682711756432,0.0541907113121977,0.720657718766397
CD300E,CMRF35-like molecule 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16159,0.0557529844206042,0.0395224144387008,-0.0217109478792494,0.133216916720458,0.158361953627104
CD300E,CMRF35-like molecule 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16159,-0.00189464462114526,0.0296548255129437,-0.0600181026265148,0.0562288133842243,0.949058664372843
CD300E,CMRF35-like molecule 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16162,-0.0667875405761787,0.0400870720611215,-0.145358201815977,0.0117831206636195,0.0957204960828254
CD300E,CMRF35-like molecule 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16162,-0.0357073285943311,0.0184606022292326,-0.0718901089636271,0.000475451774964844,0.053100453898277
CD300E,CMRF35-like molecule 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16162,-0.0653669744704275,0.0277160923694588,-0.119690515514567,-0.0110434334262884,0.0183633577980072
CD300E,CMRF35-like molecule 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16163,0.0172177278664022,0.0463154303505921,-0.0735605156207584,0.107995971353563,0.710084407841039
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20600.Liking for adding salt to foods,18724,-0.0368936920361184,0.0302233988072801,-0.0961315536983874,0.0223441696261507,0.222215155091347
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20601.Liking for aniseed,18724,-0.0257151508359709,0.0300393265836697,-0.0845922309399636,0.0331619292680218,0.391981361998025
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20602.Liking for apple juice,18724,0.12957100151191,0.0303571100924524,0.0700710657307036,0.189070937293117,1.98003913176544e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20603.Liking for apples,18724,-0.0348832570483311,0.0307979764961543,-0.0952472909807935,0.0254807768841313,0.257376753026421
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20604.Liking for asparagus,18724,-0.200707508676632,0.0307226099674382,-0.260923824212811,-0.140491193140453,6.61737647770282e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20605.Liking for aubergine,18724,-0.238688727634046,0.0301323690643149,-0.297748171000103,-0.179629284267989,2.48046854856578e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20606.Liking for avocados,18724,-0.270625061349203,0.0305615837790558,-0.330525765556152,-0.210724357142253,9.09613740541155e-19
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20607.Liking for bacon,18724,-0.0881637666712107,0.030533707397337,-0.148009833169991,-0.0283177001724302,0.00388855246398607
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20608.Liking for baked or steamed fish,18724,-0.169073903809933,0.0306768749060442,-0.22920057862578,-0.108947228994087,3.60601062608828e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20609.Liking for bananas,18724,0.0965796962806557,0.0314072448198404,0.0350214964337686,0.158137896127543,0.00210751633959468
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18724,-0.151071305257315,0.0303505727092341,-0.210558427767413,-0.0915841827472158,6.49686951260383e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20611.Liking for beef steak,18724,-0.116201064491802,0.0303638330285927,-0.175714177227844,-0.0566879517557608,0.000130159672768759
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20612.Liking for beetroot,18724,-0.0586653883141638,0.0306131104264904,-0.118667084750085,0.00133630812175745,0.0553359770784704
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20613.Liking for bell pepper,18724,-0.141023165108373,0.0302369243598961,-0.200287536853769,-0.0817587933629768,3.1235903212322e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20614.Liking for bicycling,18724,-0.124464464074079,0.0302477974221809,-0.183750147021553,-0.0651787811266044,3.89128791458026e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20615.Liking for biscuits,18724,0.184108403962424,0.0303545366886439,0.124613512052682,0.243603295872166,1.34265864380071e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20616.Liking for bitter foods,18724,-0.228184163362043,0.0302705814919174,-0.287514503086202,-0.168853823637885,4.98421011129742e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20617.Liking for bitter or ale,18724,-0.204889165004939,0.0309771556958906,-0.265604390168884,-0.144173939840993,3.83670627902421e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20618.Liking for black olives,18724,-0.247859694158115,0.0303416087655689,-0.30732924733863,-0.1883901409776,3.30649507190638e-16
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20619.Liking for black pepper,18724,-0.167551616456778,0.0305059814987435,-0.227343340194315,-0.10775989271924,4.01633319473977e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20620.Liking for blue cheese,18724,-0.226911362228067,0.0304025657527096,-0.286500391103378,-0.167322333352756,8.79050341330265e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20621.Liking for bolognese sauce,18724,-0.100320877604552,0.030550969647471,-0.160200778113595,-0.040440977095509,0.001026341923398
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20622.Liking for broad beans,18724,-0.142422340414741,0.03027197933491,-0.201755419911165,-0.0830892609183175,2.55984851669555e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20623.Liking for broccoli,18724,-0.100889418819093,0.0312285908792207,-0.162097456942366,-0.0396813806958205,0.00123711916614821
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20624.Liking for brown rice,18724,-0.146436185309862,0.0302237680401629,-0.205674770668581,-0.0871975999511427,1.27582661406305e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20625.Liking for brussel sprouts,18724,-0.100544464068448,0.0304046273619014,-0.160137533697775,-0.0409513944391215,0.000945189792355546
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20626.Liking for burgers (meat),18724,-0.0680615746348408,0.0300953455352354,-0.127048451883902,-0.0090746973857795,0.0237377930103395
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20627.Liking for burn of spicy foods,18724,-0.18521465492417,0.0301734450435538,-0.244354607209535,-0.126074702638804,8.50721855890368e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20628.Liking for butter on bread,18724,0.0288517599030551,0.0305454732364279,-0.0310173676403435,0.0887208874464537,0.344900312314795
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20629.Liking for butternut squash,18724,-0.139894361303388,0.0302385657483693,-0.199161950170192,-0.0806267724365845,3.74650817192045e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20630.Liking for cabbage,18724,-0.0668507511036482,0.0307018863740957,-0.127026448396876,-0.0066750538104206,0.0294620678916492
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20631.Liking for cake,18724,0.15187047357619,0.0303832305534382,0.0923193416914513,0.211421605460929,5.83011130108819e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20632.Liking for cake icing,18724,0.17731747866154,0.0300398697055094,0.118439334038742,0.236195623284339,3.63694471565538e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20633.Liking for capers,18724,-0.304148881935242,0.0300807015296348,-0.363107056933326,-0.245190706937157,5.68513910905114e-24
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20634.Liking for cauliflower,18724,-0.0675675104322859,0.0307574978625359,-0.127852206242856,-0.00728281462171555,0.0280482614989764
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20635.Liking for cereal or granola bar,18724,0.0904937726708385,0.0299935281228417,0.0317064575500688,0.149281087791608,0.00255540401364063
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20636.Liking for cheesecake,18724,0.041134424306798,0.0301963466267187,-0.0180504150815706,0.100319263695167,0.173141142301934
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20637.Liking for cherries,18724,-0.0872170336992817,0.0318508287079673,-0.149644657966898,-0.0247894094316659,0.00618166826848747
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20638.Liking for chicken,18724,-0.0206033932541522,0.0316865238614818,-0.0827089800226565,0.041502193514352,0.515554407708304
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20639.Liking for chilli pepper,18724,-0.237789363783126,0.030220217465866,-0.297020990016224,-0.178557737550029,3.7821026444981e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20640.Liking for chips or french fries,18724,0.0486283610634772,0.0305152914188526,-0.0111816101174739,0.108438332244428,0.111048484018068
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20641.Liking for cigarette smoking,18724,-0.0157061808691439,0.0487593649469429,-0.111274536165152,0.0798621744268642,0.747368274031229
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20642.Liking for cod,18724,-0.126762383774792,0.0312779303242136,-0.18806712721025,-0.065457640339333,5.08184960259408e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20643.Liking for coffee with sugar,18724,0.181601889778255,0.0328438188721206,0.117228004788899,0.245975774767612,3.25893092759836e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20644.Liking for coffee without sugar,18724,-0.27231276117396,0.0307012420797564,-0.332487195650283,-0.212138326697638,7.97722367754042e-19
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20645.Liking for coriander,18724,-0.206728534296501,0.0302877061902742,-0.266092438429439,-0.147364630163564,9.03102095081634e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20646.Liking for corn flakes,18724,0.211156443168204,0.0302579518640506,0.151850857514665,0.270462028821743,3.08243139901952e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20647.Liking for cream,18724,-0.00414345626797773,0.0301551377616681,-0.0632475262808472,0.0549606137448918,0.890712431880782
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20648.Liking for croissant,18724,0.0162782802023776,0.030195206405177,-0.0429043243517693,0.0754608847565244,0.58982325799729
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20649.Liking for cucumber,18724,-0.044529908228661,0.030453050937526,-0.104217888066212,0.0151580716088901,0.143690107720613
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20650.Liking for curry,18724,-0.141219508342345,0.0305990044668114,-0.201193557097296,-0.081245459587395,3.95388557230853e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20651.Liking for dairy products,18724,0.0479947904535184,0.0306846298075445,-0.0121470839692689,0.108136664876306,0.117803653027954
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20652.Liking for dark chocolate,18724,-0.152392696520187,0.0305856660393833,-0.212340601957378,-0.092444791082996,6.33322643708551e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18724,0.111345306922013,0.0312800249085509,0.0500364581012532,0.172654155742773,0.000372298694000191
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20654.Liking for dried fruit,18724,-0.0376032038795039,0.0303974987935818,-0.0971823015149242,0.0219758937559164,0.21608432279768
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20655.Liking for eggs,18724,-0.115808896254743,0.0312170370819251,-0.176994288935316,-0.0546235035741701,0.00020802521962141
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20656.Liking for exercising alone,18724,-0.176616048834503,0.0302493655372234,-0.235904805287461,-0.117327292381545,5.34902863831225e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20657.Liking for exercising with others,18724,-0.155553790981881,0.0302236717005224,-0.214792187514905,-0.0963153944488565,2.67715128669354e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18724,-0.171595020141948,0.0305174654313222,-0.231409252387339,-0.111780787896556,1.90519260014788e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20659.Liking for fatty foods,18724,-0.0404500604616963,0.0300220813256644,-0.0992933398599986,0.0183932189366059,0.17788590569543
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20660.Liking for fresh tomatoes,18724,-0.116147891722967,0.0324910643112668,-0.179830377773049,-0.0524654056728837,0.000351426674477114
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20661.Liking for fried chicken,18724,-0.0108951941368801,0.0299617973408913,-0.0696203169250271,0.0478299286512669,0.716133801455637
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20662.Liking for fried or battered fish,18724,-0.0551303240401164,0.030224387074665,-0.11437012270646,0.00410947462622699,0.0681628109108796
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20663.Liking for fruit,18724,-0.0488425653248474,0.0336313880496353,-0.114760085902133,0.0170749552524377,0.146437459732602
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20664.Liking for garlic,18724,-0.180552353110487,0.0306623121163237,-0.240650484858481,-0.120454221362492,3.9659446488337e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20665.Liking for gherkins,18724,-0.198733983630419,0.0300750038960148,-0.257680991266608,-0.13978697599423,4.00196608927506e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20666.Liking for globe artichoke,18724,-0.226541785005627,0.0302429958986554,-0.285818056966992,-0.167265513044263,7.15420800327793e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20667.Liking for goat's cheese,18724,-0.175006265949007,0.0300764746210474,-0.23395615620626,-0.116056375691754,6.02722425917501e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20668.Liking for going to a cafe,18724,0.010350932431436,0.0303644539147198,-0.0491633972414148,0.0698652621042868,0.733190378012774
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20669.Liking for going to the gym,18724,-0.160684020309298,0.0300758207871711,-0.219632629052153,-0.101735411566443,9.26788599701618e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20670.Liking for going to the pub,18724,-0.15890358374183,0.0302896247481818,-0.218271248248266,-0.0995359192353938,1.57012656890767e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20671.Liking for grapefruit,18724,-0.0995351048882329,0.0302644869695676,-0.158853499348585,-0.0402167104278804,0.00100786397431077
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20672.Liking for green olives,18724,-0.257358125847336,0.0303651858239915,-0.31687389006236,-0.197842361632313,2.51364780097399e-17
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20673.Liking for haddock,18724,-0.189193319359685,0.0311371226629601,-0.250222079779086,-0.128164558940283,1.2549801533502e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20674.Liking for ham,18724,-0.054310762445877,0.0304019864104,-0.113898655810261,0.0052771309185069,0.074047230035035
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20675.Liking for hard cheese,18724,-0.0703832458344004,0.0309394988971307,-0.131024663672777,-0.00974182799602416,0.022925177320854
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20676.Liking for herring,18724,-0.21688860590704,0.0302261273054048,-0.276131815425634,-0.157645396388447,7.47207507559374e-13
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20677.Liking for honey,18724,0.0154029200659768,0.0303025091930213,-0.0439899979523449,0.0747958380842985,0.611245387373945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18724,-0.244764502014597,0.030162720891354,-0.30388343496165,-0.185645569067543,5.16448450717735e-16
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20679.Liking for ice cream,18724,0.0540182080834438,0.0305764084594708,-0.00591155249711888,0.113947968664007,0.0773010007763021
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20680.Liking for jam,18724,0.140632274060432,0.0301729840291565,0.0814932253632852,0.199771322757579,3.17051859457085e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20681.Liking for kiwi fruit,18724,-0.0149647927619745,0.0304657900132441,-0.074677741187933,0.044748155663984,0.623290839673648
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20682.Liking for lager,18724,-0.152299319176972,0.0303799837999298,-0.211844087424834,-0.0927545509291096,5.40363579049147e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20683.Liking for lamb,18724,-0.150497815603686,0.0304690241272453,-0.210217102893087,-0.0907785283142855,7.90512650232966e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20684.Liking for lemons,18724,-0.186888649500322,0.0304269833511393,-0.246525536868555,-0.127251762132089,8.30296931278929e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20685.Liking for lentils or beans,18724,-0.0782044548037762,0.0306069667210091,-0.138194109576954,-0.0182148000305984,0.0106229813741331
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20686.Liking for liver,18724,-0.221728604170737,0.0303002947189514,-0.281117181819881,-0.162340026521592,2.62458466345068e-13
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20687.Liking for mackerel,18724,-0.22710390222932,0.0303257393630194,-0.286542351380838,-0.167665453077802,7.25834122093373e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20688.Liking for marzipan,18724,0.0412581377407004,0.0301163471234582,-0.0177699026212776,0.100286178102678,0.170716386402676
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20689.Liking for mayonnaise,18724,-0.0779281553773284,0.0301542553923329,-0.137030495946301,-0.018825814808356,0.00976471318524568
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20690.Liking for melon,18724,-0.00533356530179257,0.031464257309459,-0.0670035096283322,0.0563363790247471,0.865395864860612
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20691.Liking for milk chocolate,18724,0.131506814299798,0.030256901104087,0.0722032881357877,0.190810340463809,1.39157661570825e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20692.Liking for mushrooms,18724,-0.128026403179921,0.0311873593437824,-0.189153627493735,-0.0668991788661076,4.05901820855759e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20694.Liking for orange juice,18724,0.0888135174792575,0.0304741481525173,0.0290841871003235,0.148542847858191,0.00356808123719853
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20695.Liking for oranges,18724,-0.0741480792572608,0.030823321609256,-0.134561789611403,-0.013734368903119,0.016156299955836
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20696.Liking for pasta,18724,-0.00686155961869419,0.0306985164769277,-0.0670306519134724,0.0533075326760841,0.823137640551072
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20697.Liking for pears,18724,0.064960348376169,0.0308934874307079,0.00440911301198155,0.125511583740357,0.0355035982137618
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20698.Liking for pizza,18724,0.000532328847151134,0.0303412473532604,-0.0589365159652393,0.0600011736595415,0.98600223994082
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20699.Liking for plain yogurt,18724,-0.117913271002858,0.0304044506664423,-0.177505994309085,-0.0583205476966313,0.000105610368324149
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20700.Liking for plums,18724,-0.0106465854445716,0.031083635820014,-0.0715705116517991,0.0502773407626559,0.731967838195872
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20701.Liking for pollock,18724,-0.208773332851886,0.0300886111440722,-0.267747010694268,-0.149799655009505,4.08918740086311e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20702.Liking for pork chop,18724,-0.120806714488236,0.0302323032522792,-0.180062028862704,-0.061551400113769,6.46827549824493e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20703.Liking for porridge,18724,0.0167963188311209,0.0307537280018323,-0.0434809880524704,0.0770736257147124,0.584965541918537
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20704.Liking for potato crisps,18724,0.0168320955859778,0.0302173157070309,-0.0423938431998028,0.0760580343717583,0.577510337753493
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20705.Liking for potatoes,18724,0.0909134981867448,0.0307069345810129,0.0307279064079596,0.15109908996553,0.00307343027603754
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20706.Liking for prawns,18724,-0.300442919720108,0.0308601978009097,-0.360928907409891,-0.239956932030325,2.40160822585565e-22
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20707.Liking for raw carrots,18724,-0.0515951900395773,0.0305699620655265,-0.111512315688009,0.0083219356088547,0.0914712773327945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20708.Liking for red meat,18724,-0.126083524927489,0.0303988947352761,-0.18566535860863,-0.0665016912463477,3.37409985547611e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20709.Liking for red wine,18724,-0.302572931181334,0.0305003761087681,-0.362353668354519,-0.242792194008149,3.87523388364871e-23
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18724,0.135171882413978,0.0311753957153573,0.0740681068118772,0.196275658016078,1.45956151186601e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20711.Liking for roast chicken,18724,-0.0552594728416624,0.0317399548794661,-0.117469784405416,0.00695083872209116,0.0816988564573748
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20712.Liking for salad dressing,18724,-0.0723940366987139,0.0303095798261518,-0.131800813157971,-0.0129872602394562,0.0169277655773428
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20713.Liking for salad leaves,18724,-0.0729440159691761,0.0308660671120956,-0.133441507508883,-0.0124465244294688,0.0181259594451823
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20714.Liking for salami,18724,-0.245278583190342,0.0300847901843373,-0.304244771951643,-0.18631239442904,3.77498265999002e-16
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20715.Liking for salmon,18724,-0.204519011241116,0.0316766922106192,-0.26660532797393,-0.142432694508302,1.09823154476097e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20716.Liking for salty foods,18724,-0.056901778660698,0.0299936341098795,-0.115689301516062,0.00188574419466578,0.0578263686947443
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20717.Liking for salty pretzels,18724,-0.0818802950472222,0.0301734807233445,-0.141020317264977,-0.0227402728294669,0.00666071958431036
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20718.Liking for sardines,18724,-0.237283271327582,0.0301702340937094,-0.296416930151252,-0.178149612503912,3.89640076604723e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20719.Liking for sausages (meat),18724,-0.0595774521077839,0.0302146613328039,-0.118798188320079,-0.000356715895488323,0.0486464657158868
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20720.Liking for savoury biscuits,18724,-0.00858528485026286,0.0303644299936415,-0.0680995676378002,0.0509289979372744,0.777378121287231
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18724,-0.325321215553267,0.0303663352356975,-0.384839232615234,-0.2658031984913,1.05474964702953e-26
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20722.Liking for skimmed milk,18724,0.0612244963976219,0.0301168244116536,0.00219552055078081,0.120253472244463,0.042076709197787
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20723.Liking for smoked fish,18724,-0.213580496848497,0.0303663043724128,-0.273098453418426,-0.154062540278568,2.08419593730185e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20724.Liking for soft cheese,18724,-0.119853087983196,0.0303166050131546,-0.179273633808979,-0.060432542157413,7.73381331076862e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20725.Liking for soy sauce,18724,-0.129374675875867,0.0303237854979508,-0.18880929545185,-0.0699400562998834,1.99591325865202e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20726.Liking for soya milk,18724,-0.0522471335824855,0.0303146628937166,-0.11166387285417,0.00716960568919897,0.0848157939992284
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20727.Liking for spicy foods,18724,-0.194144431424782,0.0303364839191284,-0.253603939906274,-0.134684922943291,1.59379044000477e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20728.Liking for spinach,18724,-0.189715591789002,0.030594495942061,-0.249680803835441,-0.129750379742562,5.72925770563649e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20729.Liking for spirits,18724,-0.194492592116822,0.0302239375588677,-0.253731509732202,-0.135253674501441,1.26427784520976e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20730.Liking for strawberries,18724,-0.0126452051353878,0.0330416760950011,-0.0774068902815898,0.0521164800108143,0.701943069695543
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18724,0.150363815809232,0.0308668592490468,0.0898647716811008,0.210862859937364,1.11734926685745e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20732.Liking for sweet foods,18724,0.213996139992608,0.0302848583139654,0.154637817697236,0.27335446228798,1.64944953556519e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20733.Liking for taking the stairs,18724,-0.24652176385278,0.0309901901883916,-0.307262536622027,-0.185780991083532,1.89532820903741e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20734.Liking for tea with sugar,18724,0.241515084050814,0.0362069418675359,0.170549477990444,0.312480690111184,2.62231621232687e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20735.Liking for tea without sugar,18724,-0.0891909178316547,0.0314576015457918,-0.150847816861407,-0.0275340188019028,0.00458355237966035
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20736.Liking for tomato ketchup,18724,0.0492857664532197,0.0301203441127269,-0.00975010800772504,0.108321640914164,0.101794703540076
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20737.Liking for tinned tuna,18724,-0.10259193535575,0.0303689982598943,-0.162115171945143,-0.043068698766357,0.000731162007347873
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20738.Liking for turnip (white),18724,-0.0442077421360623,0.0300624571629756,-0.103130158175495,0.0147146739033699,0.141435118019918
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20739.Liking for vegetables,18724,-0.0678630703071542,0.0333903273051794,-0.133308111825306,-0.00241802878900269,0.0421255549481555
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20740.Liking for vinegar,18724,-0.0773733137745944,0.0302557604366352,-0.136674604230399,-0.0180720233187894,0.0105563800517655
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20741.Liking for watching television,18724,0.135548316818275,0.0305487624286693,0.0756727424580833,0.195423891178467,9.16940506333929e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20742.Liking for whisky,18724,-0.161379126361398,0.0313793961984009,-0.222882742910264,-0.0998755098125324,2.73350603431923e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20743.Liking for white bread,18724,0.148139431552985,0.0299547195476932,0.0894281812395065,0.206850681866464,7.6628624024059e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20744.Liking for white rice,18724,0.0539668218985177,0.0303997592941143,-0.00561670631794636,0.113550350114982,0.0758747825000288
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20745.Liking for white wine,18724,-0.25564787464382,0.0301669778692269,-0.314775151267505,-0.196520598020135,2.53538292543274e-17
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18724,-0.0448919908680718,0.0306737499703209,-0.105012540809901,0.0152285590737572,0.143338883150287
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20747.Liking for whole milk,18724,0.0398127010283017,0.0301384936638945,-0.0192587465529316,0.0988841486095349,0.186520283386427
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20748.Liking for wholemeal bread,18724,-0.0523346993851704,0.0315908661161452,-0.114252796972815,0.00958339820247421,0.097609011407703
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20749.Liking for working up a sweat,18724,-0.219965730146085,0.030392510080032,-0.279535049902947,-0.160396410389222,4.74738520703129e-13
CD300E,CMRF35-like molecule 2,Physical measures,X21001.Body mass index (BMI),51535,-0.0514641488730318,0.00879647109716319,-0.0687052322234717,-0.034223065522592,4.92919187965124e-09
CD300E,CMRF35-like molecule 2,Physical measures,X21002.Weight,51575,0.0164479477411846,0.00496927628559637,0.00670816622141573,0.0261877292609535,0.000933838856196342
CD300E,CMRF35-like molecule 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,17170,0.010802908389973,0.00360032139588585,0.00374627845403675,0.0178595383259093,0.00269888552431237
CD300E,CMRF35-like molecule 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17882,0.0342162971553207,0.0322628927551561,-0.0290189726447852,0.0974515669554266,0.288910397865052
CD300E,CMRF35-like molecule 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17899,0.0160923339577089,0.0334900655626481,-0.0495481945450813,0.0817328624604991,0.630870193712484
CD300E,CMRF35-like molecule 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17901,-0.0066021206668956,0.0329899632153525,-0.0712624485689865,0.0580582072351953,0.841384995716983
CD300E,CMRF35-like molecule 2,Health and medical history,X21040.Satisfaction with bowel habits,17824,0.0685386022899706,0.030661020211418,0.00844300267559139,0.12863420190435,0.0254056803936254
CD300E,CMRF35-like molecule 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17804,0.0991349967299131,0.0326497538648187,0.0351414791548685,0.163128514304958,0.00239834261066874
CD300E,CMRF35-like molecule 2,Health and medical history,X21042.Greatest number of times bowels opened per day,17813,-0.0197179242896808,0.0328147052115955,-0.0840347465044079,0.0445988979250463,0.547923015607093
CD300E,CMRF35-like molecule 2,Health and medical history,X21043.Least number of times bowels opened per week,17688,-0.00495716834769515,0.0326917354381621,-0.0690329698064929,0.0591186331111026,0.879477593770623
CD300E,CMRF35-like molecule 2,Health and medical history,X21044.Average number of times bowels opened per day,17749,0.0765064520480213,0.0365838440512671,0.00480211770753772,0.148210786388505,0.0365186625814956
CD300E,CMRF35-like molecule 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17910,-0.0162764995781894,0.033279985024385,-0.081505270225984,0.0489522710696051,0.624792660347989
CD300E,CMRF35-like molecule 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17900,-0.0629961101890191,0.0333750659540357,-0.128411239458929,0.00241901908089084,0.0591065721257358
CD300E,CMRF35-like molecule 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10064,0.110580140863569,0.0530002765590229,0.0066995988078843,0.214460682919254,0.0369669331467416
CD300E,CMRF35-like molecule 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17905,-0.018196185497515,0.0362719621815441,-0.0892892313733415,0.0528968603783115,0.615913016060882
CD300E,CMRF35-like molecule 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17902,-0.14790158321548,0.0494270037674012,-0.244778510599586,-0.0510246558313734,0.00277240459483434
CD300E,CMRF35-like molecule 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17903,-0.106786765011565,0.0390281155117066,-0.18328187141451,-0.0302916586086203,0.00622240683387769
CD300E,CMRF35-like molecule 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17901,-0.256531051336605,0.0937130727846598,-0.440208673994538,-0.0728534286786719,0.00619863593526006
CD300E,CMRF35-like molecule 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17909,-0.0353435527795926,0.0381451621538245,-0.110108070601089,0.0394209650419034,0.354170641170694
CD300E,CMRF35-like molecule 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17905,-0.278382456963369,0.0377274075054283,-0.352328175674009,-0.20443673825273,1.66733085587231e-13
CD300E,CMRF35-like molecule 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17493,0.118075942093622,0.0345243126980907,0.0504082892053643,0.18574359498188,0.000627455704911437
CD300E,CMRF35-like molecule 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17899,-0.0251400191120839,0.0339828724386615,-0.0917464490918604,0.0414664108676926,0.459440175795359
CD300E,CMRF35-like molecule 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17906,-0.0815107268207889,0.049292386339826,-0.178123804046848,0.0151023504052701,0.0982229052391992
CD300E,CMRF35-like molecule 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17909,-0.201668426113354,0.033353436835329,-0.267041162310599,-0.13629568991611,1.5105267764939e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17906,0.0147402241844709,0.033223830569158,-0.0503784837310789,0.0798589321000206,0.657290747978707
CD300E,CMRF35-like molecule 2,Working and living environment,X21100.Water hardness (USGS classification),51265,-0.021380255753358,0.0183554666152682,-0.0573569703192837,0.0145964588125677,0.244109610435561
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2139.Age first had sexual intercourse,44707,0.000133744690343842,0.00225162600285414,-0.00427944227525027,0.00454693165593795,0.952634448686928
CD300E,CMRF35-like molecule 2,Health and medical history,X2149.Lifetime number of sexual partners,41495,-0.108221542304501,0.0210405107722542,-0.149460943418119,-0.0669821411908826,2.7091345870848e-07
CD300E,CMRF35-like molecule 2,Physical activities,X22032.IPAQ activity group,41465,-0.258573804911755,0.0206293926376295,-0.299007414481509,-0.218140195342001,5.63674820368212e-36
CD300E,CMRF35-like molecule 2,Physical activities,X22033.Summed days activity,42561,-0.0319679725117283,0.00219089670382649,-0.0362621300512282,-0.0276738149722284,4.1726365743085e-48
CD300E,CMRF35-like molecule 2,Physical activities,X22034.Summed minutes activity,41465,-0.0244515952653288,0.00221364956540321,-0.0287903484135191,-0.0201128421171385,2.51532789926977e-28
CD300E,CMRF35-like molecule 2,Physical activities,X22037.MET minutes per week for walking,39692,-0.0163830477274459,0.00225115384414612,-0.0207953092619723,-0.0119707861929195,3.46036394200956e-13
CD300E,CMRF35-like molecule 2,Physical activities,X22038.MET minutes per week for moderate activity,41465,-0.0196937391977469,0.00221709686040468,-0.02403924904414,-0.0153482293513537,6.78328860256017e-19
CD300E,CMRF35-like molecule 2,Physical activities,X22039.MET minutes per week for vigorous activity,41465,-0.306032611626499,0.0208004754422603,-0.346801543493329,-0.265263679759669,7.09241670616845e-49
CD300E,CMRF35-like molecule 2,Physical activities,X22040.Summed MET minutes per week for all activity,39692,-0.0263063955576075,0.00225782753091973,-0.0307317375182102,-0.0218810535970048,2.54477774832008e-31
CD300E,CMRF35-like molecule 2,Eye measures,X2217.Age started wearing glasses or contact lenses,44008,-0.00368960593529083,0.00221331772223961,-0.00802770867088046,0.000648496800298802,0.0955210474033397
CD300E,CMRF35-like molecule 2,Working and living environment,X22501.Year ended full time education,12563,-0.0475638695235718,0.00972353393581365,-0.0666219960377666,-0.0285057430093771,1.01248147691301e-06
CD300E,CMRF35-like molecule 2,Lifestyle factors,X22506.Tobacco smoking,12481,-0.100225079497237,0.0777643476732427,-0.252643200936793,0.0521930419423184,0.197480865226374
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48386,-0.189360951390589,0.0502697024710856,-0.287889568233917,-0.0908323345472614,0.000165482832123572
CD300E,CMRF35-like molecule 2,Physical measures,X23098.Weight,50700,0.0184386646002168,0.00498689111062773,0.00866435802338648,0.0282129711770472,0.000218025592193776
CD300E,CMRF35-like molecule 2,Physical measures,X23099.Body fat percentage,50671,0.0696857031037459,0.00476741650682498,0.0603415667503689,0.0790298394571228,2.74213546345375e-48
CD300E,CMRF35-like molecule 2,Physical measures,X23100.Whole body fat mass,50618,0.0573650264123193,0.00460576425399982,0.0483377284744797,0.066392324350159,1.48029980088784e-35
CD300E,CMRF35-like molecule 2,Physical measures,X23101.Whole body fat-free mass,50694,-0.0254271223445774,0.00416945216843719,-0.0335992485947143,-0.0172549960944405,1.07885756592681e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23102.Whole body water mass,50700,-0.0259253023810635,0.00417499562528219,-0.0341082938066166,-0.0177423109555104,5.35102106771089e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23104.Body mass index (BMI),50700,-0.0447267101052408,0.00880177608854346,-0.061978191238786,-0.0274752289716956,3.75684451094184e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23105.Basal metabolic rate,50698,-0.0190939177880864,0.0044620478650722,-0.0278395316036279,-0.0103483039725449,1.87924611510735e-05
CD300E,CMRF35-like molecule 2,Physical measures,X23106.Impedance of whole body,50694,0.0638145939096615,0.00339979514563068,0.0571509954242254,0.0704781923950976,2.44693048890177e-78
CD300E,CMRF35-like molecule 2,Physical measures,X23107.Impedance of leg (right),50697,0.0168248422732656,0.00278162263223002,0.0113728619140948,0.0222768226324365,1.4715615829492e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23108.Impedance of leg (left),50696,0.0164708837647151,0.00276339636753889,0.0110546268843389,0.0218871406450913,2.53315464184523e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23109.Impedance of arm (right),50687,0.0782291527334485,0.00338227549492499,0.0715998927633955,0.0848584127035014,9.62936340390446e-118
CD300E,CMRF35-like molecule 2,Physical measures,X23110.Impedance of arm (left),50695,0.0786835496881908,0.00338512732198325,0.0720487001371037,0.085318399239278,6.88691146294001e-119
CD300E,CMRF35-like molecule 2,Physical measures,X23111.Leg fat percentage (right),50696,0.00582000917749228,0.00577909276685291,-0.00550701264553943,0.017147031000524,0.313901103301328
CD300E,CMRF35-like molecule 2,Physical measures,X23112.Leg fat mass (right),50695,0.0181356460546138,0.00614879320406975,0.00608401137463704,0.0301872807345905,0.00318470735573526
CD300E,CMRF35-like molecule 2,Physical measures,X23113.Leg fat-free mass (right),50694,0.00273088876700206,0.00436363446601713,-0.00582183478639152,0.0112836123203956,0.531429960635398
CD300E,CMRF35-like molecule 2,Physical measures,X23114.Leg predicted mass (right),50693,0.00349123715606251,0.00438540189600799,-0.00510415056011315,0.0120866248722382,0.42597516400095
CD300E,CMRF35-like molecule 2,Physical measures,X23115.Leg fat percentage (left),50690,0.00267835226575209,0.00602399988157118,-0.00912868750212742,0.0144853920336316,0.656600917201575
CD300E,CMRF35-like molecule 2,Physical measures,X23116.Leg fat mass (left),50690,0.0208656122327005,0.00641235103417832,0.00829740420571096,0.03343382025969,0.00113877938028753
CD300E,CMRF35-like molecule 2,Physical measures,X23117.Leg fat-free mass (left),50687,0.00487617832146877,0.00455852805567694,-0.00405853666765802,0.0138108933105956,0.284767278568793
CD300E,CMRF35-like molecule 2,Physical measures,X23118.Leg predicted mass (left),50686,0.00558158463631749,0.00458132659665834,-0.00339781549313285,0.0145609847657678,0.223102856638017
CD300E,CMRF35-like molecule 2,Physical measures,X23119.Arm fat percentage (right),50686,0.0796566174000086,0.00530322341699418,0.0692622995027,0.0900509352973172,6.94778041576203e-51
CD300E,CMRF35-like molecule 2,Physical measures,X23120.Arm fat mass (right),50681,0.0576658339300239,0.00525656095962899,0.0473629744491511,0.0679686934108967,5.71162243231648e-28
CD300E,CMRF35-like molecule 2,Physical measures,X23121.Arm fat-free mass (right),50682,-0.0393942710450482,0.00419745484322,-0.0476212825377594,-0.031167259552337,6.52543473901619e-21
CD300E,CMRF35-like molecule 2,Physical measures,X23122.Arm predicted mass (right),50681,-0.0397827985414428,0.00420322878690092,-0.0480211269637686,-0.031544470119117,3.06203342774738e-21
CD300E,CMRF35-like molecule 2,Physical measures,X23123.Arm fat percentage (left),50676,0.0854461254051159,0.00543506364548582,0.0747934006599637,0.0960988501502681,1.46379925500757e-55
CD300E,CMRF35-like molecule 2,Physical measures,X23124.Arm fat mass (left),50675,0.0571489464876314,0.00524459489405808,0.0468695404952776,0.0674283524799853,1.28214773859806e-27
CD300E,CMRF35-like molecule 2,Physical measures,X23125.Arm fat-free mass (left),50671,-0.0377367091656599,0.00427693749706787,-0.046119506659913,-0.0293539116714069,1.14591789561006e-18
CD300E,CMRF35-like molecule 2,Physical measures,X23126.Arm predicted mass (left),50668,-0.0378811658017868,0.00429036018922494,-0.0462902717726677,-0.0294720598309059,1.08554508961762e-18
CD300E,CMRF35-like molecule 2,Physical measures,X23127.Trunk fat percentage,50664,0.0593186110354145,0.00341710787358583,0.0526210796031863,0.0660161424676427,2.62925076266082e-67
CD300E,CMRF35-like molecule 2,Physical measures,X23128.Trunk fat mass,50660,0.0551971468000735,0.00376439158755394,0.0478189392884678,0.0625753543116792,1.40036411999905e-48
CD300E,CMRF35-like molecule 2,Physical measures,X23129.Trunk fat-free mass,50653,-0.0339448246859217,0.00377905227969334,-0.0413517671541206,-0.0265378822177227,2.73872002337178e-19
CD300E,CMRF35-like molecule 2,Physical measures,X23130.Trunk predicted mass,50648,-0.0337571953998082,0.00378127193156018,-0.0411684883856662,-0.0263459024139503,4.50081725015759e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23400.Total Cholesterol,29642,-0.0434413147682936,0.00276145037474431,-0.0488537575027925,-0.0380288720337948,1.54847222553498e-55
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29642,-0.0242872840640054,0.00268348425174999,-0.0295469131974354,-0.0190276549305755,1.50585698975966e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29642,-0.0124446189617319,0.00269181382073513,-0.0177205740503727,-0.00716866387309104,3.79576986111444e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23403.VLDL Cholesterol,29642,0.0126660893369395,0.00269869485537196,0.00737664742041048,0.0179555312534686,2.69884799870603e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,29642,-0.0348502937228064,0.00268203237676804,-0.0401070771812718,-0.0295935102643411,1.68664930656211e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23405.LDL Cholesterol,29642,-0.0340319306246064,0.00267495517430446,-0.0392748427662431,-0.0287890184829696,5.54705658741623e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23406.HDL Cholesterol,29642,-0.0857760011609603,0.00308055098844549,-0.0918138810983135,-0.0797381212236071,1.86700952406348e-168
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23407.Total Triglycerides,29642,0.0278451689397381,0.00285370247613346,0.0222519120865165,0.0334384257929597,1.85103718817606e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23408.Triglycerides in VLDL,29642,0.0243681983789881,0.00287662209915904,0.0187300190646364,0.0300063776933399,2.54135090559944e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23409.Triglycerides in LDL,29642,0.0358309717756536,0.0027613988945122,0.0304186299424097,0.0412433136088975,2.13990917906328e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23410.Triglycerides in HDL,29642,0.0276298942330876,0.00274980090517935,0.0222402844589361,0.0330195040072392,1.02364137548177e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29642,-0.0427030327879298,0.00280350754835469,-0.048197907582705,-0.0372081579931546,3.42047909768207e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23412.Phospholipids in VLDL,29642,0.0219963960726619,0.00275906502389276,0.0165886286258321,0.0274041635194917,1.611696166801e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23413.Phospholipids in LDL,29642,-0.0307892023927807,0.00267034951970253,-0.0360230874513976,-0.0255553173341637,1.08282378278417e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23414.Phospholipids in HDL,29642,-0.0682791437012656,0.00298311200339492,-0.0741260432279196,-0.0624322441746116,6.010418615411e-115
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23415.Total Esterified Cholesterol,29642,-0.0482080985437364,0.00277256603878706,-0.053642327979759,-0.0427738691077137,2.21716923157616e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29642,0.00979631497407022,0.00268374037439619,0.00453618384025368,0.0150564461078868,0.000262438639777275
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29642,-0.0310208904952533,0.00267094279029551,-0.0362559383642325,-0.0257858426262741,4.07646098488946e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29642,-0.0886408491500219,0.00306735483156822,-0.0946528646198956,-0.0826288336801482,4.12100308415637e-181
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23419.Total Free Cholesterol,29642,-0.0310967949714809,0.00273452053551586,-0.036456455221092,-0.0257371347218698,6.65538262257255e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,29642,0.0163100054767472,0.00273432138100686,0.0109507355699737,0.0216692753835206,2.47528662673967e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23421.Free Cholesterol in LDL,29642,-0.0410886284048784,0.00269763218389748,-0.0463759874853175,-0.0358012693244394,3.45355866784656e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23422.Free Cholesterol in HDL,29642,-0.0692765887794222,0.00309333113604409,-0.0753395178060687,-0.0632136597527758,3.58472206056342e-110
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29642,-0.0279016705448424,0.00271248724233797,-0.0332181455398248,-0.02258519554986,8.93526032424924e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23424.Total Lipids in VLDL,29642,0.0210279013966013,0.00279495991042534,0.0155497799721676,0.0265060228210349,5.48373328382629e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23425.Total Lipids in LDL,29642,-0.0299887661977707,0.00267295782980616,-0.0352277635441908,-0.0247497688513507,3.75322136954251e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23426.Total Lipids in HDL,29642,-0.073492221236805,0.00302187571259807,-0.0794150976334972,-0.0675693448401128,2.23646024705499e-129
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29642,-0.0798198718458659,0.00282570331272078,-0.0853582503387986,-0.0742814933529332,3.00891508651905e-173
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23428.Concentration of VLDL Particles,29642,0.0199290665448561,0.00271973282675615,0.014598390204414,0.0252597428852981,2.40320772224415e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23429.Concentration of LDL Particles,29642,-0.0105563215942506,0.00267167413057667,-0.0157928028901809,-0.00531984029832034,7.79400964942265e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23430.Concentration of HDL Particles,29642,-0.0832808676361858,0.00283281813313784,-0.088833191177136,-0.0777285440952356,2.81298414800723e-187
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29642,0.0135210887501762,0.00299167739544483,0.00765740105510438,0.0193847764452481,6.22055120741656e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,29642,-0.0139229540900609,0.00279707552787045,-0.0194052221246869,-0.00844068605543479,6.47107311103991e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,29642,-0.0282382717294615,0.00319300941677861,-0.0344965701863476,-0.0219799732725754,9.75546381972716e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23434.Phosphoglycerides,29619,-0.0466896129847234,0.00281944717472849,-0.0522157294471913,-0.0411634965222556,2.56713197190924e-61
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29619,0.0587120863636135,0.00301518924803338,0.0528023154374681,0.0646218572897589,6.34962766788405e-84
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23436.Total Cholines,29619,-0.0496295810985906,0.00284322571121922,-0.0552023034925803,-0.044056858704601,6.85996067509361e-68
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23437.Phosphatidylcholines,29619,-0.0527520047806219,0.00285248266424614,-0.0583428708025444,-0.0471611387586995,6.25886845324226e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23438.Sphingomyelins,29618,-0.0395663783955217,0.00286907539640772,-0.0451897661724809,-0.0339429906185626,3.94591147708824e-43
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23439.Apolipoprotein B,29642,-0.00853010840847188,0.00267523606480878,-0.0137735710954971,-0.00328664572144668,0.00143139792353418
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23440.Apolipoprotein A1,29642,-0.0759768138811479,0.00293755095824603,-0.0817344137593101,-0.0702192140029857,7.0656363664963e-146
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29642,0.0297451758020059,0.00272601000002904,0.024402196201949,0.0350881554020628,1.14517355784711e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23442.Total Fatty Acids,29619,-0.00342422350566033,0.00272464364281873,-0.00876452504558504,0.00191607803426439,0.208850421905174
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23443.Degree of Unsaturation,29619,-0.0712271023806174,0.00291594992793987,-0.0769423642393795,-0.0655118405218552,1.74545593613965e-130
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,29619,-0.050832361874525,0.00276171737167686,-0.0562453279230116,-0.0454193958260384,3.09053854564979e-75
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,29619,-0.019130975186492,0.00272472170375109,-0.0244714297258442,-0.0137905206471399,2.24617925599283e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29619,-0.0293377044449276,0.00273483152554687,-0.0346979742349994,-0.0239774346548557,8.47673856236377e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29619,0.0277385275191443,0.00278878774129502,0.0222725035462061,0.0332045514920825,2.84287628049894e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23448.Saturated Fatty Acids,29619,-0.00579651228106716,0.00273792592699578,-0.0111628470979789,-0.000430177464155422,0.0342581501393209
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23449.Linoleic Acid,29619,-0.0103826378108044,0.00271676135946817,-0.015707490075362,-0.0050577855462468,0.000132807574858525
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23450.Docosahexaenoic Acid,29619,-0.0739196739914978,0.00282299859384071,-0.0794527512354256,-0.06838659674757,1.99714046445445e-149
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29619,-0.0607830961868866,0.00277854295298241,-0.0662290403747322,-0.0553371519990411,3.01097121065392e-105
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29619,-0.0263237187293165,0.00291276624009246,-0.0320327405598977,-0.0206146968987353,1.70015951155096e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29619,-0.0549547319614141,0.00295502997304431,-0.0607465907085809,-0.0491628732142473,9.30914941943514e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29619,0.0874171266282375,0.00298276153222069,0.081570914025085,0.0932633392313901,3.81574475989472e-186
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29619,-0.0101751872787049,0.00273552693819311,-0.0155368200775634,-0.0048135544798464,0.000199871812045568
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29619,-0.0140007353964025,0.0029118760917679,-0.0197080125362676,-0.00829345825653741,1.53081367171347e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29619,-0.074375531753768,0.00283810321509977,-0.0799382140553635,-0.0688128494521724,1.15783683515557e-149
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29619,-0.0767243194763993,0.00299320083530778,-0.0825909931136025,-0.0708576458391961,2.4109261882035e-143
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29617,0.0489388960807002,0.00275728388306199,0.0435346196698987,0.0543431724915017,4.05741249425791e-70
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23460.Alanine,29632,-0.0117022211827843,0.00272012318867768,-0.0170336626325925,-0.00637077973297605,1.69734472948026e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23461.Glutamine,29561,-0.0145778856503216,0.00270520286134653,-0.0198800832585608,-0.00927568804208235,7.14588786409015e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23462.Glycine,29607,0.0161738362987764,0.00285769430026665,0.0105727554702537,0.021774917127299,1.52993899002995e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23463.Histidine,29605,-0.0323595810824924,0.00268091266371691,-0.0376141699033775,-0.0271049922616072,1.81559470460895e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29620,-0.0200031172653192,0.00284876630599448,-0.0255866992250684,-0.01441953530557,2.23946586031354e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23465.Isoleucine,29636,-0.00672461146727044,0.00278054486917172,-0.012174479410847,-0.00127474352369387,0.0155927348351153
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23466.Leucine,29637,-0.0193254831542694,0.00284089694034057,-0.024893641157337,-0.0137573251512019,1.0470097094791e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23467.Valine,29620,-0.0237158535372035,0.00285297183724781,-0.0293076783382092,-0.0181240287361978,9.75176563163869e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23468.Phenylalanine,29631,0.0348625626337602,0.00271025574592727,0.0295504613717428,0.0401746638957777,9.15383547498562e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23469.Tyrosine,29609,-0.00572201341916237,0.00276447055118556,-0.0111403756994861,-0.00030365113883868,0.0384759280489664
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23470.Glucose,29587,-0.0234810389093064,0.00272838815455417,-0.0288286796922325,-0.0181333981263802,7.92034582598784e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23471.Lactate,29589,0.0282407506858878,0.0027044018698371,0.0229401230210071,0.0335413783507685,1.75601757356732e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23472.Pyruvate,29560,0.0259838424520329,0.0027010076286765,0.0206898674998269,0.0312778174042388,7.0840481129937e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23473.Citrate,29638,0.0316549207729662,0.00273727687445415,0.026289858099036,0.0370199834468963,7.27403340776632e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23474.3-Hydroxybutyrate,29159,0.0357610437300965,0.0027458876159155,0.0303791040029022,0.0411429834572909,1.15363539857796e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23475.Acetate,29617,-0.0300469729718921,0.00269879920960797,-0.0353366194227238,-0.0247573265210605,9.8337507221147e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23476.Acetoacetate,29640,0.00309844976737891,0.0027035030348206,-0.00220041618086946,0.00839731571562728,0.251768399984686
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23477.Acetone,29640,-0.0111023392570555,0.00270302374147227,-0.0164002657903412,-0.00580441272376984,4.01250498095238e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23478.Creatinine,28902,0.146659291098474,0.00309407567138562,0.140594902782558,0.152723679414389,0
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23479.Albumin,29639,-0.0878864955708804,0.00269076417587772,-0.0931603933556007,-0.08261259778616,6.46774431895874e-230
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23480.Glycoprotein Acetyls,29642,0.105636626879118,0.00280763439497488,0.100133663464967,0.111139590293269,1.13587138734604e-302
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29642,0.0362114878788425,0.00288362149068989,0.0305595897570903,0.0418633860005947,4.46041362807073e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29642,0.032757998310778,0.00287851507962178,0.0271161087547193,0.0383998878668367,6.05832926579939e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29642,0.037916884314948,0.00289486135935255,0.032242956050617,0.043590812579279,4.3419957020747e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29642,0.0375154754385078,0.00286683227070451,0.0318964841879269,0.0431344666890886,5.07789406792034e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29642,0.0370389440295969,0.00285614848039701,0.0314408930080187,0.042636995051175,2.35908977055932e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29642,0.0363201604071649,0.00286894667145167,0.0306970249311196,0.0419432958832102,1.22956232286245e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29642,0.0277845495475629,0.00286790939917883,0.0221634471251724,0.0334056519699534,3.65485745907031e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29642,0.0286661565294144,0.00289934775531363,0.0229834349289996,0.0343488781298291,5.1403647158728e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29642,0.0265217125902024,0.00289571037374107,0.0208461202576699,0.0321973049227349,5.56744337155405e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29642,0.0298068791649247,0.00287821526993545,0.0241655772358512,0.0354481810939982,4.33667114611344e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29642,0.0258111546096359,0.00281847047650653,0.0202869524756831,0.0313353567435887,5.62468327550944e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29642,0.022424594587894,0.00278094511748255,0.0169739421576282,0.0278752470181597,7.6812582893578e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29642,0.028884412120484,0.00285380449194643,0.023290955316269,0.034477868924699,4.86012760953995e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29642,0.0250835848750889,0.00292314668789874,0.0193542173668074,0.0308129523833704,9.85502770817089e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29642,0.024723475481363,0.00286441465302912,0.0191092227614259,0.0303377282013,6.36697193349871e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,29642,0.0196990383033328,0.00286023533150707,0.014092977053579,0.0253050995530867,5.80329592428055e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,29642,0.0281553586921369,0.0028739543307296,0.0225224082039069,0.0337883091803669,1.25868169700198e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,29642,0.0236982918830222,0.0028054064683238,0.0181996952051076,0.0291968885609368,3.11382810486354e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29642,0.0224137819797261,0.00275512109952548,0.0170137446246561,0.027813819334796,4.26782740150323e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29642,0.0245405435150796,0.00286112487271326,0.0189327387645616,0.0301483482655976,1.01838851146074e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,29642,0.0127124666177329,0.00287332813299157,0.00708074347706939,0.0183441897583963,9.71000094003142e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29642,0.00266819186234836,0.00269700626792921,-0.0026179404227929,0.00795432414748961,0.322516563153148
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29642,0.00458237486185382,0.00271992009659922,-0.000748668527480654,0.00991341825118829,0.092048094001987
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29642,0.00239625396810931,0.00269063034083871,-0.00287738149993457,0.00766988943615318,0.37315530200235
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29642,-0.00913372032424922,0.00268244822685716,-0.0143913188488893,-0.00387612179960919,0.000662531957499372
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29642,-0.0147049132687748,0.00270832864858508,-0.0200132374200015,-0.009396589117548,5.6950689658162e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29642,-0.00124859587299266,0.00268007478810212,-0.00650154245767282,0.00400435071168751,0.641304119764223
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29642,0.0133832162899905,0.00282131173048484,0.00785344529824018,0.0189129872817408,2.1091495317256e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29642,0.0276076067968499,0.00275068831972274,0.0222162576901933,0.0329989559035065,1.14798151251002e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,29642,0.0230666630722078,0.00274194458586329,0.0176924516839158,0.0284408744604998,4.19086136736444e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,29642,0.0104895970106743,0.00269728629190558,0.0052029158785394,0.0157762781428093,0.000100900720104219
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,29642,0.0131522237714393,0.00268946037310121,0.00788088144016097,0.0184235661027177,1.01217854602601e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29642,0.020367708852463,0.00269988901032108,0.0150759263922337,0.0256594913126923,4.69166737190423e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29642,0.000558755021803017,0.00267793160348783,-0.00468999092103313,0.00580750096463916,0.834721570559829
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,29642,0.0350403768338964,0.00282277077405789,0.029507746116743,0.0405730075510499,2.70382474595567e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29642,0.0206275034219488,0.00271323533980608,0.0153095621559289,0.0259454446879688,2.9893415216364e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29642,0.0216578549181012,0.00272229766430295,0.0163221514960675,0.026993558340135,1.84392901822392e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29642,0.0318243237903615,0.00271497011836989,0.0265029823583565,0.0371456652223665,1.15791248172471e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29642,0.0018311983903531,0.00275906625245515,-0.00357657146445898,0.00723896824516519,0.506886084003928
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29642,-0.00585709496077523,0.00278011200089781,-0.0113061144825349,-0.000408075439015524,0.0351447077194708
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29642,0.0192825060590499,0.00272235532295346,0.0139466896260611,0.0246183224920387,1.44187918710799e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29642,0.0482572973876236,0.00277104451073932,0.0428260501465745,0.0536885446286726,1.38321578157715e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23523.Concentration of IDL Particles,29642,-0.0157901725745813,0.00270475142531887,-0.0210914853682063,-0.0104888597809563,5.34011109945541e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23524.Total Lipids in IDL,29642,-0.0306303206887056,0.00276931478204326,-0.0360581776615104,-0.0252024637159008,2.21353892555283e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23525.Phospholipids in IDL,29642,-0.0212206688407609,0.00277581217751222,-0.0266612607086848,-0.0157800769728369,2.15507694262902e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23526.Cholesterol in IDL,29642,-0.0399971818833944,0.00277617736810933,-0.0454384895248887,-0.0345558742419001,6.71007770187185e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29642,-0.0426463199046567,0.00277381102177331,-0.0480829895073323,-0.037209650301981,3.88694896211575e-53
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23528.Free Cholesterol in IDL,29642,-0.031492766842215,0.0027782860979704,-0.036938207594237,-0.0260473260901931,1.00996691393668e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23529.Triglycerides in IDL,29642,0.043368794325002,0.00274804140936781,0.0379826331626411,0.0487549554873629,7.0261451023073e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,29642,-0.0103313516346382,0.00267669624843429,-0.0155776762815694,-0.00508502698770699,0.000113748385729406
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23531.Total Lipids in Large LDL,29642,-0.0344490365783847,0.00269095251401679,-0.0397233035058576,-0.0291747696509118,2.01327974368889e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23532.Phospholipids in Large LDL,29642,-0.0359637415612461,0.00268652603013333,-0.0412293325803074,-0.0306981505421848,9.50047216608373e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23533.Cholesterol in Large LDL,29642,-0.0383503339727624,0.00269574308696995,-0.0436339904232235,-0.0330666775223013,8.91209096306418e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29642,-0.0363205087211907,0.00268755820107987,-0.0415881227953072,-0.0310528946470741,1.70925739737772e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29642,-0.043058259407396,0.00272409111069277,-0.0483974779843539,-0.0377190408304382,4.76043094391807e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23536.Triglycerides in Large LDL,29642,0.0354111955674763,0.00275019102502954,0.0300208211584184,0.0408015699765342,7.77206132895458e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29642,-0.0140269145504728,0.00267405033644212,-0.0192680532098993,-0.00878577589104623,1.56870745837481e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,29642,-0.0241094815354857,0.0026691954825269,-0.0293411046812384,-0.018877858389733,1.77728458129637e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,29642,-0.025827967008628,0.002665868719097,-0.0310530696980582,-0.0206028643191979,3.64410738223381e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,29642,-0.0271691319917833,0.00266634604971383,-0.0323951702492224,-0.0219430937343442,2.41931293177858e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29642,-0.022512536654194,0.00267542087398435,-0.0277563615672034,-0.0172687117411847,4.11811761379128e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29642,-0.0382162991889147,0.00266637749085445,-0.0434423990709895,-0.03299019930684,1.95618378992389e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,29642,0.0349143055478435,0.00277659556158636,0.0294721782471342,0.0403564328485527,3.60814333892266e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,29642,-0.00339769843714224,0.00267411668340419,-0.00863896713661446,0.00184357026232997,0.20388551866449
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23545.Total Lipids in Small LDL,29642,-0.0170494476722805,0.00266896617626113,-0.0222806213777523,-0.0118182739668087,1.70523163071568e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23546.Phospholipids in Small LDL,29642,-0.015600166488516,0.00266818326319299,-0.0208298056843743,-0.0103705272926577,5.06560586369089e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23547.Cholesterol in Small LDL,29642,-0.0221198790358887,0.00266589405911313,-0.0273450313917504,-0.016894726680027,1.10916359282985e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29642,-0.0168219859285468,0.0026729452747155,-0.0220609586669892,-0.0115830131901044,3.14874759158578e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29642,-0.0335510404653041,0.00266945618727895,-0.0387831745923708,-0.0283189063382373,3.8915385301997e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23550.Triglycerides in Small LDL,29642,0.036773879611245,0.00280738942666779,0.0312713963349761,0.0422763628875139,4.287594826124e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29642,-0.0126670314173066,0.00314710118816786,-0.0188353497461156,-0.00649871308849758,5.71207999091306e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29642,-0.011794888202894,0.00316128827608607,-0.0179910132240227,-0.00559876318176526,0.000191047917536622
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29642,-0.00787151949678295,0.00315340275183275,-0.0140521888903751,-0.00169085010319077,0.0125586208605818
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29642,-0.0212964766493131,0.0031650127325786,-0.0274999016051671,-0.015093051693459,1.74280030214728e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29642,-0.0282965255341956,0.00319781906712151,-0.0345642509057538,-0.0220288001626374,9.3363850326523e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29642,0.00201208575594413,0.00300763184534041,-0.00388287266092307,0.00790704417281133,0.503504921455285
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29642,0.0365090171378985,0.0027123839365967,0.031192744622169,0.041825289653628,3.5483157328456e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,29642,-0.0535729181174285,0.00323779124015213,-0.0599189889481267,-0.0472268472867303,3.21577601882004e-61
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23559.Total Lipids in Large HDL,29642,-0.0535810249237764,0.00321412836713278,-0.0598807165233567,-0.0472813333241962,4.1259985611164e-62
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23560.Phospholipids in Large HDL,29642,-0.0536085436036787,0.00317671882473036,-0.0598349125001502,-0.0473821747072072,1.35276133533983e-63
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23561.Cholesterol in Large HDL,29642,-0.0566191868598829,0.00323483390657974,-0.0629594613167792,-0.0502789124029866,3.00154254828653e-68
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29642,-0.0586460868012203,0.00323360889493805,-0.0649839602352989,-0.0523082133671417,4.09138151658092e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29642,-0.0477887684156246,0.00322138065839204,-0.054102674506073,-0.0414748623251762,1.31396101189973e-49
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23564.Triglycerides in Large HDL,29642,0.0212032841410127,0.00277942727768146,0.0157556066767571,0.0266509616052684,2.4432629966815e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29642,-0.0768464897013466,0.00290947857769603,-0.0825490677136308,-0.0711439116890624,5.68382994073232e-152
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,29642,-0.0733208866930785,0.00287551336264083,-0.0789568928838546,-0.0676848805023025,6.98827850865138e-142
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,29642,-0.0674520734245893,0.00284677104704088,-0.0730317446767894,-0.0618724021723891,5.76897472505548e-123
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,29642,-0.0854242378305591,0.00292303257192986,-0.0911533816715417,-0.0796950939895766,4.02795591883666e-185
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29642,-0.0865936440374592,0.00291198135392159,-0.0923011274911455,-0.0808861605837728,1.6716422863551e-191
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29642,-0.0771890383843974,0.00295664519048709,-0.0829840629577521,-0.0713940138110427,1.45985584574709e-148
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,29642,0.0203053095210011,0.00275392298553921,0.0149076204693442,0.0257029985726579,1.70897542244216e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,29642,-0.0692963915755541,0.00265092738008776,-0.0744922092405261,-0.0641005739105821,6.20330972528236e-149
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23573.Total Lipids in Small HDL,29642,-0.0607843679864499,0.00267601336491765,-0.0660293541816885,-0.0555393817912113,2.99129870082602e-113
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23574.Phospholipids in Small HDL,29642,-0.0592348511156163,0.00268940783472209,-0.0645060904716716,-0.053963611759561,1.18629514669053e-106
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23575.Cholesterol in Small HDL,29642,-0.0748800240433248,0.00264649417245206,-0.0800671526213308,-0.0696928954653188,8.40853052873447e-174
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29642,-0.0773802360770906,0.00263696684025925,-0.0825486910839988,-0.0722117810701825,1.32294647756324e-186
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29642,-0.0563406033842066,0.00270564521745534,-0.0616436680104191,-0.0510375387579942,1.28900541134993e-95
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23578.Triglycerides in Small HDL,29642,0.0352629151949171,0.00288139450599319,0.0296153819631705,0.0409104484266637,2.35389366159038e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28377,0.03965372877898,0.00273923911848271,0.0342848201067539,0.0450226374512061,2.52792364563468e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28377,0.00722643041933077,0.0027863383470782,0.0017652072590575,0.012687653579604,0.00950472009894227
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28377,0.00801514050525202,0.00275944752433299,0.00260662335755937,0.0134236576529447,0.00367985615207072
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28377,0.00414451629821969,0.00281610509154129,-0.00137504968120124,0.00966408227764062,0.141107780419165
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28377,-0.0171843114327829,0.00274518078088119,-0.02256486576331,-0.0118037571022558,3.90959826146154e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29328,0.0375114928282126,0.00267819977809131,0.0322622212631536,0.0427607643932716,1.9861522283515e-44
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29328,-0.0160821594899245,0.00292745801420768,-0.0218199771977716,-0.0103443417820775,3.97187504788952e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29328,-0.0215261808365156,0.00292187747532318,-0.027253060688149,-0.0157993009848821,1.78783294425815e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29328,0.00845326732843575,0.00284214427035754,0.00288266455853498,0.0140238700983365,0.00293938150943541
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29328,0.00359685209640981,0.00285567351876621,-0.00200026800037196,0.00919397219319157,0.207843222134196
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29637,0.0650788119184253,0.00281964280864277,0.0595523120134855,0.0706053118233651,7.81616686596724e-117
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29637,0.0135159264862103,0.00275646230206836,0.00811326037415629,0.0189185925982643,9.47094799028214e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29637,0.00432286176161568,0.00285949297462078,-0.00128174446864105,0.00992746799187242,0.130606070866164
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29637,0.035743841350965,0.00269262411734472,0.0304662980809694,0.0410213846209607,4.22491370888551e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29637,-0.036888758525344,0.00266538440744211,-0.0421129119639305,-0.0316646050867574,1.99813419007626e-43
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29642,-0.0115845559587069,0.0028172875061946,-0.0171064394708483,-0.0060626724465655,3.93382040712302e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29642,-0.02932199,0.002934961,-0.03507451,-0.02356946,1.825497e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29642,-0.0323014303276,0.00295480070433398,-0.0380928397080946,-0.0265100209471054,9.17292710038927e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29642,-0.0198807549055615,0.00287053457717156,-0.0255070026768178,-0.0142545071343053,4.4235528695248e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29642,0.0255933784318675,0.00291253409777157,0.0198848116002352,0.0313019452634998,1.6126319475005e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29642,-0.0499909682875558,0.00284583850964594,-0.0555688117664618,-0.0444131248086497,9.95739526203533e-69
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29642,-0.0232136878256731,0.00277523418051226,-0.0286531468194772,-0.0177742288318691,6.2939487694915e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29642,-0.00056273827512317,0.00271440551050272,-0.0058829730757085,0.00475749652546216,0.835764912042243
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29642,-0.051649346527595,0.00286223103528381,-0.0572593193567512,-0.0460393736984387,2.10562585932889e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29642,0.0316660822447533,0.00279886355483224,0.0261803096772821,0.0371518548122245,1.28819174087078e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29642,0.0918914970640511,0.00274780352230459,0.0865058021603341,0.0972771919677681,1.020876479718e-240
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29642,-0.0612504956804188,0.00290124801236435,-0.0669369417846529,-0.0555640495761847,3.28391544022195e-98
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29642,-0.0670542763385379,0.00292579417691233,-0.0727888329252861,-0.0613197197517897,3.07283443774123e-115
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29642,-0.00927809833016119,0.00271123084426249,-0.0145921107849157,-0.00396408587540671,0.000622237745641497
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29642,0.0467037944282862,0.00289076309241325,0.0410378987671563,0.0523696900894162,1.82632611711634e-58
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29642,0.0668943325409083,0.00264191445160065,0.061716180215771,0.0720724848660456,5.87906551105036e-140
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29642,-0.0796013417291192,0.00276889525733905,-0.0850283764335037,-0.0741743070247347,2.75633818125518e-179
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29642,-0.0857525532471618,0.00274049789726073,-0.0911239291257928,-0.0803811773685307,1.72934351750997e-211
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29642,-0.0163258905133656,0.00273281337896926,-0.0216822047361453,-0.0109695762905858,2.3411127487276e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29642,0.074735386444165,0.00283241920144926,0.0691838448093244,0.0802869280790055,1.13433803602535e-151
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29642,-0.00450491315731336,0.00268897043565091,-0.00977529521118914,0.000765468896562418,0.0938800318207951
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29642,-0.0769848649896318,0.00281859156480229,-0.0825093044566442,-0.0714604255226193,3.03089098102309e-162
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29642,-0.0440537439558816,0.00266114667992055,-0.0492695914485259,-0.0388378964632373,2.80561408641584e-61
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29642,-0.0573753548137269,0.00292807580526205,-0.0631143833920405,-0.0516363262354133,5.90484122954131e-85
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29642,0.0770636285235423,0.00278570038214083,0.0716036557745463,0.0825236012725384,2.47075220944539e-166
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29642,-0.00900143167408634,0.00269455208498821,-0.0142827537606632,-0.00372010958750946,0.000836995714208511
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29642,-0.0570733898895054,0.00270255517347907,-0.0623703980295244,-0.0517763817494864,2.86582700423753e-98
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29642,-0.00291337935454646,0.00274868992166675,-0.00830081160101328,0.00247405289192036,0.289191633842956
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29642,-0.055047499979537,0.00290683833829976,-0.0607449031226045,-0.0493500968364694,1.66111221386741e-79
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29642,0.0701117661503284,0.00273466489076526,0.0647518229644285,0.0754717093362283,2.10518596650439e-143
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29642,0.0113999104265142,0.00270745724933376,0.00609329421782001,0.0167065266352083,2.5548994116295e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29642,-0.0526516174355193,0.00268046938191354,-0.0579053374240698,-0.0473978974469688,2.33478904743421e-85
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29642,-0.00809062799205018,0.00270526805187913,-0.0133929533737333,-0.00278830261036709,0.00278573347067229
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29642,-0.0554792785174919,0.00280543892387427,-0.0609779388082855,-0.0499806182266984,1.74695656285181e-86
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29642,0.0601513931393059,0.00281141300885807,0.0546410236419441,0.0656617626366677,8.54659733483268e-101
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29628,0.00585047077650962,0.00302799670216815,-8.44027597399662e-05,0.0117853443127592,0.0533534979491984
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29628,-0.0307924921661382,0.00281877767753272,-0.0363172964141023,-0.0252676879181741,9.99202629806379e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29628,-0.063925376281243,0.00268738183756408,-0.0691926446828686,-0.0586581078796175,6.59281856390854e-124
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29628,0.0327514985251212,0.00318166848280743,0.0265154282988186,0.0389875687514237,8.27402396101587e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29628,0.0409206922578303,0.00297334667027578,0.0350929327840898,0.0467484517315709,5.81076817281098e-43
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29642,0.00933783253108481,0.00296932363340161,0.00351795820961766,0.015157706852552,0.00166383071250306
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29642,-0.044899089561249,0.00303294244999121,-0.0508436567632317,-0.0389545223592662,2.07944859358668e-49
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29642,-0.0490004276356143,0.00298317009384639,-0.0548474410195532,-0.0431534142516753,2.31936657249554e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29642,-0.00477404725312292,0.00294176465237282,-0.0105399059717737,0.000991811465527815,0.104631787279172
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29642,0.0630478674399951,0.00290724600750638,0.0573496652652826,0.0687460696147076,1.75969617511259e-103
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29642,0.0684310287648926,0.00297879567265772,0.0625925892464835,0.0742694682833017,8.99272817876677e-116
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29642,-0.072960835572578,0.00292434251608621,-0.078692546904107,-0.067229124241049,5.49470560177764e-136
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29642,-0.0642731056606935,0.00284956156886279,-0.0698582463356645,-0.0586879649857224,1.03782785272976e-111
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29642,-0.0694632769436105,0.00311034741939437,-0.0755595578856234,-0.0633669960015975,1.4210715723979e-109
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29642,0.0693113305336235,0.00285843967610512,0.0637087887684574,0.0749138722987895,1.24869636029235e-128
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29642,0.00590368470835665,0.00276015030057292,0.000493790119233719,0.0113135792974796,0.032451941288903
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29642,-0.0516408967883487,0.00274122518804372,-0.0570136981569144,-0.046268095419783,1.05195223868358e-78
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29642,-0.0533811882305363,0.00272316719840978,-0.0587185959394195,-0.0480437805216532,5.08452832424975e-85
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29642,0.00632716827825224,0.00287457761468065,0.000692996153478163,0.0119613404030263,0.0277382174034037
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29642,0.0763667795850566,0.00290302607321665,0.070676848481552,0.0820567106885613,8.87194978830508e-151
CD300E,CMRF35-like molecule 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51027,-0.00393009924965067,0.00230182193671196,-0.00844167024560611,0.000581471746304764,0.0877563592664023
CD300E,CMRF35-like molecule 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51027,-0.00317267271383008,0.00224671093655633,-0.00757622614948049,0.00123088072182033,0.157914537357666
CD300E,CMRF35-like molecule 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47589,0.000605289072918696,0.00214616137068336,-0.00360118721362069,0.00481176535945809,0.777919167933143
CD300E,CMRF35-like molecule 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47589,-0.00132226957611829,0.00233604985863828,-0.0059009272990493,0.00325638814681273,0.57137743174312
CD300E,CMRF35-like molecule 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47589,-0.00465077994426783,0.00230160671959597,-0.00916192911467592,-0.000139630773859738,0.0433198752549006
CD300E,CMRF35-like molecule 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47589,-0.00132259437140775,0.00211385133719464,-0.00546574299230924,0.00282055424949374,0.531527896764445
CD300E,CMRF35-like molecule 2,Working and living environment,X24009.Traffic intensity on the nearest road,51027,-0.106661782752982,0.0404817713298969,-0.18600605455958,-0.0273175109463838,0.00842097855049202
CD300E,CMRF35-like molecule 2,Working and living environment,X24010.Inverse distance to the nearest road,51027,0.00296669983606798,0.00201230046514673,-0.000977409075619609,0.00691080874775557,0.140411652237239
CD300E,CMRF35-like molecule 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51027,0.00318040147821563,0.00201114761262853,-0.000761447842536283,0.00712225079896754,0.113795915290408
CD300E,CMRF35-like molecule 2,Working and living environment,X24012.Inverse distance to the nearest major road,51027,-0.00489728949177971,0.00204342118639117,-0.00890239501710639,-0.00089218396645302,0.016550973350956
CD300E,CMRF35-like molecule 2,Working and living environment,X24013.Total traffic load on major roads,51027,-0.0613542143706662,0.0280238169999029,-0.116280895690476,-0.00642753305085656,0.0285752239605169
CD300E,CMRF35-like molecule 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51027,-0.0820850203449542,0.0272402240206617,-0.135475859425451,-0.0286941812644573,0.0025848589569483
CD300E,CMRF35-like molecule 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51027,-0.00457645147562499,0.00229812595901874,-0.00908077835530172,-7.21245959482645e-05,0.04644400047143
CD300E,CMRF35-like molecule 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51027,-0.00491937388006011,0.00229532828964174,-0.00941821732775792,-0.000420530432362291,0.0321008383103304
CD300E,CMRF35-like molecule 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51027,-0.00358305577352269,0.00227084336381099,-0.00803390876659222,0.00086779721954684,0.114605710674055
CD300E,CMRF35-like molecule 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50923,-0.00177827110700368,0.00223047199822915,-0.00614999622353281,0.00259345400952545,0.425302462294069
CD300E,CMRF35-like molecule 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51027,-0.00504849976273421,0.00202012082398585,-0.00900793657774647,-0.00108906294772195,0.0124537600902097
CD300E,CMRF35-like molecule 2,Working and living environment,X24021.Average evening sound level of noise pollution,51027,-0.00503471980473491,0.00201999910621818,-0.00899391805292253,-0.00107552155654728,0.012690143384592
CD300E,CMRF35-like molecule 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51027,-0.00505617167241947,0.00202014033888384,-0.00901564673663179,-0.00109669660820715,0.0123217831920416
CD300E,CMRF35-like molecule 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51027,-0.00503732898543402,0.00202003027521604,-0.00899658832485745,-0.00107806964601059,0.0126454376091648
CD300E,CMRF35-like molecule 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51027,-0.00504556137789082,0.002020042078462,-0.00900484385167633,-0.0010862789041053,0.0125015318684673
CD300E,CMRF35-like molecule 2,Health and medical history,X2405.Number of children fathered,23503,-0.104606229373311,0.0302600055671709,-0.163915840284966,-0.0452966184616565,0.000547366325022513
CD300E,CMRF35-like molecule 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45533,0.00428284210068932,0.00236202050929975,-0.000346718097538193,0.00891240229891684,0.0698058325116344
CD300E,CMRF35-like molecule 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45533,0.00632559781960951,0.00213936210300368,0.00213244809772229,0.0105187475414967,0.00311041263709902
CD300E,CMRF35-like molecule 2,Working and living environment,"X24502.Water percentage, buffer 1000m",45533,-0.00341050425381778,0.00212810456374069,-0.00758158919874953,0.000760580691113976,0.109029529565179
CD300E,CMRF35-like molecule 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45533,0.00194879423426468,0.0022229748530375,-0.00240823647768882,0.00630582494621818,0.380675696837593
CD300E,CMRF35-like molecule 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45533,0.00576576565220494,0.00215826304792675,0.00153557007826852,0.00999596122614136,0.00755434904156318
CD300E,CMRF35-like molecule 2,Working and living environment,"X24505.Water percentage, buffer 300m",45533,-0.000933803115071802,0.00214016910897222,-0.00512853456865735,0.00326092833851375,0.662605107089247
CD300E,CMRF35-like molecule 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51266,0.00295328865869581,0.00226478348977152,-0.00148568698125638,0.007392264298648,0.192237784625181
CD300E,CMRF35-like molecule 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51266,0.00113515157071657,0.00212889977318413,-0.00303749198472432,0.00530779512615746,0.593890232061763
CD300E,CMRF35-like molecule 2,Working and living environment,X24508.Distance (Euclidean) to coast,51266,0.00448577985063666,0.00202390912654354,0.000518917962611315,0.008452641738662,0.0266689107803703
CD300E,CMRF35-like molecule 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11229,0.0918865439539183,0.0412163109486869,0.011102574494492,0.172670513413345,0.0258088022546789
CD300E,CMRF35-like molecule 2,Health and medical history,X2704.Years since last cervical smear test,21165,0.100098656782635,0.0303277190495732,0.0406563274454712,0.159540986119798,0.000966494407773984
CD300E,CMRF35-like molecule 2,Health and medical history,X2714.Age when periods started (menarche),27009,-0.00273599773918035,0.0256801717974076,-0.0530691344620993,0.0475971389837386,0.915153716355894
CD300E,CMRF35-like molecule 2,Health and medical history,X2734.Number of live births,27842,0.0247938685583805,0.0247016809556385,-0.023621426114671,0.073209163231432,0.315516520084788
CD300E,CMRF35-like molecule 2,Health and medical history,X2744.Birth weight of first child,22063,-0.213001934158942,0.0275534864166893,-0.267006767535653,-0.158997100782231,1.11704621858478e-14
CD300E,CMRF35-like molecule 2,Health and medical history,X2754.Age at first live birth,18788,-0.0212740125036162,0.00343605819296021,-0.0280086865618182,-0.0145393384454141,6.08700108650535e-10
CD300E,CMRF35-like molecule 2,Health and medical history,X2764.Age at last live birth,18738,-0.015076287032354,0.0033178060651964,-0.0215791869201389,-0.00857338714456901,5.55275826093943e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X2794.Age started oral contraceptive pill,21365,0.00244654845771828,0.00366840931483207,-0.00474353379935258,0.00963663071478915,0.50482819241081
CD300E,CMRF35-like molecule 2,Health and medical history,X2804.Age when last used oral contraceptive pill,19375,-0.00349220032883024,0.00318278152675107,-0.00973045212126234,0.00274605146360186,0.27256041806634
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2867.Age started smoking in former smokers,12634,-0.0146384627720742,0.00423226704952751,-0.0229337061891481,-0.00634321935500026,0.000544427624044892
CD300E,CMRF35-like molecule 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19685,-0.0383187470511368,0.0383150979627816,-0.113416339058189,0.0367788449559152,0.317276723150987
CD300E,CMRF35-like molecule 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19675,0.0141924280390806,0.0422593309507548,-0.0686358606243988,0.09702071670256,0.736994139060233
CD300E,CMRF35-like molecule 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19715,0.112377386195815,0.0432966820886916,0.0275158893019792,0.19723888308965,0.00945180733733114
CD300E,CMRF35-like molecule 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19658,0.0565511167251239,0.0423663945819388,-0.0264870166554761,0.139589250105724,0.181953782496026
CD300E,CMRF35-like molecule 2,Mental health,X28739.Difficulty with standing for long periods,19735,0.329099937186664,0.0368091555251005,0.256953992357467,0.401245882015861,4.20065955232722e-19
CD300E,CMRF35-like molecule 2,Mental health,X28740.Difficulty with taking care of household responsibilities,19780,0.297560793734584,0.0407298773411067,0.217730234146015,0.377391353323153,2.86284485622601e-13
CD300E,CMRF35-like molecule 2,Mental health,X28741.Difficulty learning a new task,19622,0.0749644096241938,0.0464563608238209,-0.0160900575904951,0.166018876838883,0.106618977956955
CD300E,CMRF35-like molecule 2,Mental health,X28742.Difficulty with joining in community activities,18914,0.165829976627871,0.0463759395791244,0.074933135052787,0.256726818202954,0.000350061717674494
CD300E,CMRF35-like molecule 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19646,0.135871399681486,0.0396238222857847,0.0582087080013479,0.213534091361624,0.000606979928756407
CD300E,CMRF35-like molecule 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19780,0.132997378275246,0.0560535030459612,0.0231325123051621,0.24286224424533,0.0176687687707705
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,12001,0.0801289639863423,0.0392565085930528,0.00318620714395874,0.157071720828726,0.0412564055636914
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2897.Age stopped smoking,12640,0.0373624241093824,0.00440145346947715,0.0287355753092072,0.0459892729095576,2.32240940626702e-17
CD300E,CMRF35-like molecule 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17653,-0.000835859856036509,0.00676245891405151,-0.0140902793275775,0.0124185596155044,0.901631066707189
CD300E,CMRF35-like molecule 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17653,0.00576603197394218,0.00736689307979464,-0.00867307846245531,0.0202051424103397,0.433816619367353
CD300E,CMRF35-like molecule 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17653,0.0162124971997157,0.0244817593254221,-0.0317717510781116,0.064196745477543,0.507834007670864
CD300E,CMRF35-like molecule 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17653,-0.0163421551417148,0.0253199130667202,-0.0659691847524864,0.0332848744690567,0.518658916161094
CD300E,CMRF35-like molecule 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17653,-0.00691031515464879,0.0282850444572815,-0.0623490022909205,0.0485283719816229,0.806993691875103
CD300E,CMRF35-like molecule 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17653,-0.0435462624388268,0.0238798970186267,-0.0903508605953351,0.00325833571768149,0.068236562972682
CD300E,CMRF35-like molecule 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17653,-0.0237255358373078,0.0106205041752433,-0.0445417240207847,-0.00290934765383091,0.0254997097245666
CD300E,CMRF35-like molecule 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17653,0.00889849678856699,0.0192142778260257,-0.0287614877504434,0.0465584813275774,0.643284798193204
CD300E,CMRF35-like molecule 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17535,0.0858826765434476,0.0441443368805595,-0.000640223742449056,0.172405576829344,0.0517311594561917
CD300E,CMRF35-like molecule 2,Mental health,X29003.Recent feelings of depression,17522,0.0600621689138093,0.0427579805454456,-0.0237434729552641,0.143867810782883,0.160128014484795
CD300E,CMRF35-like molecule 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17543,0.0573753177165863,0.0345459805514348,-0.0103348041642259,0.125085439597398,0.0967636380854471
CD300E,CMRF35-like molecule 2,Mental health,X29005.Recent feelings of tiredness or low energy,17553,0.173307567212001,0.0347430660341154,0.105211157785135,0.241403976638867,6.15069811319048e-07
CD300E,CMRF35-like molecule 2,Mental health,X29006.Recent poor appetite or overeating,17566,0.133354384521887,0.0481139242584718,0.0390510929752819,0.227657676068491,0.00558337532940107
CD300E,CMRF35-like molecule 2,Mental health,X29007.Recent feelings of inadequacy,17494,0.0392025787822042,0.04645323625083,-0.0518457642694225,0.130250921833831,0.398728504736595
CD300E,CMRF35-like molecule 2,Mental health,X29008.Recent trouble concentrating on things,17561,0.00826260413750298,0.0460377457823075,-0.0819713775958197,0.0984965858708257,0.857567164214427
CD300E,CMRF35-like molecule 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17546,0.150880879494141,0.0792389730080537,-0.00442750760164398,0.306189266589926,0.056910311424414
CD300E,CMRF35-like molecule 2,Mental health,X29010.Recent thoughts of suicide or self-harm,17460,0.279880477742906,0.0872525008633735,0.108865576050693,0.450895379435118,0.00134039182339501
CD300E,CMRF35-like molecule 2,Mental health,X29038#0.Substances taken for depression_None of options listed,16145,-0.0107521567556421,0.0140872556381342,-0.0383631778063851,0.016858864295101,0.445322984246552
CD300E,CMRF35-like molecule 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16145,-0.00966911360992828,0.0273084759179957,-0.0631937264091999,0.0438554991893433,0.723291009651934
CD300E,CMRF35-like molecule 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16145,-0.0249414327099737,0.0139963208940135,-0.0523742216622402,0.00249135624229287,0.0747681667538316
CD300E,CMRF35-like molecule 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16145,0.015968857665287,0.0410771659976448,-0.0645423876900968,0.0964801030206709,0.697464252113537
CD300E,CMRF35-like molecule 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16145,-0.0208738907173944,0.0262572337948257,-0.0723380689552527,0.0305902875204639,0.426638715760799
CD300E,CMRF35-like molecule 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16145,0.0205369272424192,0.0279461808978872,-0.0342375873174397,0.0753114418022781,0.462426797248734
CD300E,CMRF35-like molecule 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16145,0.0126950063198456,0.03135633079562,-0.0487634020395697,0.0741534146792609,0.685583862806048
CD300E,CMRF35-like molecule 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16145,-0.0180087001364146,0.0369118889744618,-0.0903560025263598,0.0543386022535306,0.625639021081669
CD300E,CMRF35-like molecule 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16145,-0.0174419922177566,0.0273907294828506,-0.0711278220041437,0.0362438375686306,0.524274254150733
CD300E,CMRF35-like molecule 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16145,-0.0136051474049648,0.0138325554300935,-0.040716956047948,0.0135066612380184,0.325346681109346
CD300E,CMRF35-like molecule 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16145,-0.0205902895518639,0.0214652132406493,-0.0626621075035366,0.0214815283998087,0.337452268281374
CD300E,CMRF35-like molecule 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16145,-0.0378458044990062,0.0338326797226564,-0.104157856755413,0.0284662477574004,0.263320303477199
CD300E,CMRF35-like molecule 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16145,-0.0482043603046746,0.0437555692483243,-0.13396527603139,0.037556555422041,0.270619987769367
CD300E,CMRF35-like molecule 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16145,-0.0496729897328863,0.0270522385560332,-0.102695377302711,0.00334939783693865,0.0663482828512368
CD300E,CMRF35-like molecule 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16145,-0.0196332004116385,0.0441519208428303,-0.106170965263586,0.0669045644403089,0.656561504687722
CD300E,CMRF35-like molecule 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16145,-0.0487379774652242,0.0429932495331888,-0.133004746550274,0.0355287916198258,0.256971120718679
CD300E,CMRF35-like molecule 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16145,-0.00420605046621607,0.0232613221494931,-0.0497982418792225,0.0413861409467903,0.856513221311672
CD300E,CMRF35-like molecule 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16145,-0.00888287259700361,0.0226117997099321,-0.0532020000284706,0.0354362548344633,0.6944411122839
CD300E,CMRF35-like molecule 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16145,-0.030439201969703,0.0322424156702771,-0.0936343366834461,0.0327559327440401,0.345146360210378
CD300E,CMRF35-like molecule 2,Mental health,X29058.Recent feelings or nervousness or anxiety,17279,-0.0752011780154158,0.0405897653955194,-0.154757118190634,0.0043547621598021,0.0639405893668587
CD300E,CMRF35-like molecule 2,Mental health,X29059.Recent inability to stop or control worrying,17298,0.0297273911412881,0.0419837794605041,-0.0525608166012999,0.112015598883876,0.478912278254456
CD300E,CMRF35-like molecule 2,Mental health,X29060.Recent worrying too much about different things,17287,-0.0232013495031777,0.0387476147255088,-0.0991466743651749,0.0527439753588195,0.54932654603282
CD300E,CMRF35-like molecule 2,Mental health,X29061.Recent trouble relaxing,17290,-0.046942210887906,0.0411420103649379,-0.127580551203184,0.0336961294273722,0.253894064578157
CD300E,CMRF35-like molecule 2,Mental health,X29062.Recent restlessness,17309,0.0483506301233909,0.0583359897357232,-0.0659879097586265,0.162689170005408,0.407211935290554
CD300E,CMRF35-like molecule 2,Mental health,X29063.Recent easy annoyance or irritability,17262,-0.0408113423141198,0.0418002588456488,-0.122739849651592,0.0411171650233518,0.328908779027036
CD300E,CMRF35-like molecule 2,Mental health,X29064.Recent feelings of foreboding,17253,0.0240392471043383,0.0473000589218998,-0.0686688683825853,0.116747362591262,0.611299474861411
CD300E,CMRF35-like molecule 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16145,-0.0186260490621137,0.0147850998663101,-0.0476048448000815,0.0103527466758541,0.207765108775789
CD300E,CMRF35-like molecule 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16145,-0.0443851409960375,0.0247789828189814,-0.0929519473212411,0.00418166532916617,0.0732732984833047
CD300E,CMRF35-like molecule 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16145,-0.0224633504754176,0.0318144038469015,-0.0848195820153445,0.0398928810645094,0.480151787106391
CD300E,CMRF35-like molecule 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16145,0.0365366275015086,0.0337310593750493,-0.0295762488735881,0.102649503876605,0.278747111858049
CD300E,CMRF35-like molecule 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,16145,-0.0133716482287835,0.022280067102793,-0.0570405797502579,0.0302972832926908,0.548406748754298
CD300E,CMRF35-like molecule 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16145,-0.00664984187184017,0.0240736575588418,-0.05383421068717,0.0405345269434897,0.782375738760148
CD300E,CMRF35-like molecule 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16145,-0.0163397674231141,0.0240104218500238,-0.0634001942491608,0.0307206594029325,0.49617988539154
CD300E,CMRF35-like molecule 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16145,-0.0183958795936267,0.0222616350227114,-0.0620286842381411,0.0252369250508877,0.408618373266525
CD300E,CMRF35-like molecule 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16145,-0.00829359382627279,0.0293945577175528,-0.0659069269526763,0.0493197393001307,0.777834218495388
CD300E,CMRF35-like molecule 2,Mental health,X29076.Felt loved as a child,17227,-0.0440849559308735,0.0361008901346559,-0.114842700594799,0.0266727887330521,0.222042248674245
CD300E,CMRF35-like molecule 2,Mental health,X29077.Physically abused by family as a child,17251,-0.0246910554131231,0.0486257393273331,-0.119997504494696,0.0706153936684497,0.611615902509604
CD300E,CMRF35-like molecule 2,Mental health,X29078.Felt hated by family member as a child,17224,0.0472555866143134,0.0489344937660782,-0.0486560211671998,0.143167194395827,0.334212535280932
CD300E,CMRF35-like molecule 2,Mental health,X29079.Sexually molested as a child,17098,-0.0547841744991225,0.0658660097731185,-0.183881553654435,0.0743132046561898,0.405560663050204
CD300E,CMRF35-like molecule 2,Mental health,X29080.Someone to take to doctor when needed as a child,17192,-0.0751598324039857,0.0519030820875508,-0.176889873295585,0.0265702084876139,0.14761283909921
CD300E,CMRF35-like molecule 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17228,0.0246646022052971,0.0680622295769955,-0.108737367765614,0.158066572176208,0.717070210686767
CD300E,CMRF35-like molecule 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17121,-0.00267868303477839,0.053064425025007,-0.106684956083792,0.101327590014235,0.959740613416953
CD300E,CMRF35-like molecule 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17241,0.0106903580392589,0.0596531178768574,-0.106229752999382,0.127610469077899,0.857775935997891
CD300E,CMRF35-like molecule 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17191,0.113418696398745,0.0825316088319343,-0.0483432569118456,0.275180649709337,0.169383394112635
CD300E,CMRF35-like molecule 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17189,-0.0265883303960982,0.0799650584160992,-0.183319844891653,0.130143184099456,0.73951628435052
CD300E,CMRF35-like molecule 2,Mental health,X29086.Experienced a violent or sexual assault,17242,0.0990901732377354,0.0676491292272529,-0.0335021200476803,0.231682466523151,0.143002903460251
CD300E,CMRF35-like molecule 2,Mental health,X29087.Experienced a life-threatening injury or illness,17243,0.243036161738689,0.041987587557132,0.16074049012671,0.325331833350668,7.23439716424632e-09
CD300E,CMRF35-like molecule 2,Mental health,X29088.Experienced a marital separation or divorce,17250,-0.00966565511796053,0.0393940792010295,-0.0868780503519784,0.0675467401160573,0.806182115911537
CD300E,CMRF35-like molecule 2,Mental health,X29089.Experienced the death of a spouse or partner,17269,-0.000333032644487695,0.0527517326248091,-0.103726428589114,0.103060363300138,0.994962895496524
CD300E,CMRF35-like molecule 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17245,0.066917698318032,0.0491728185261011,-0.0294610259931261,0.16329642262919,0.173573315451356
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29091.Frequency of drinking alcohol,17254,-0.413615588445519,0.0327663790395841,-0.477837691363104,-0.349393485527934,2.27944616859568e-36
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15379,-0.306512002318867,0.0383034438647174,-0.381586752293713,-0.231437252344021,1.30890392270246e-15
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15417,-0.271977154572303,0.0386513006283476,-0.347733703803864,-0.196220605340741,2.05164626281117e-12
CD300E,CMRF35-like molecule 2,Mental health,X29104.Ever used cannabis,17242,-0.170366691064536,0.0476678043729476,-0.263795587635513,-0.0769377944935584,0.000352474312547372
CD300E,CMRF35-like molecule 2,Mental health,X29108.Ever thought that life not worth living,17160,0.0562571879686693,0.0411505554466394,-0.0243979007067438,0.136912276644083,0.171609879078471
CD300E,CMRF35-like molecule 2,Mental health,X29109.Ever contemplated self-harm,17202,0.0820393735680426,0.0556307190300781,-0.0269968357309104,0.191075582866996,0.140307896007957
CD300E,CMRF35-like molecule 2,Mental health,X29111.Ever self-harmed,17229,0.0660778060126673,0.0897984616856053,-0.109927178891119,0.242082790916454,0.461834671934245
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17223,-0.00402382307272061,0.05941554101317,-0.120478283458534,0.112430637313093,0.946006600048712
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17472,-0.0438287732681058,0.031291897300841,-0.105160891977754,0.0175033454415426,0.16133866353483
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17472,-0.0695114280702825,0.0239960185948919,-0.116543624516271,-0.0224792316242945,0.00377470228685827
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17472,-0.0720713768531523,0.0257560946435892,-0.122553322354587,-0.0215894313517174,0.00514404335544357
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17472,-0.0544677634646317,0.0348142704657989,-0.122703733577597,0.0137682066483342,0.117712674307539
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17207,-0.155896048832059,0.0370317406803088,-0.228478260565464,-0.0833138370986534,2.56901168032734e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X29153.Pain or discomfort today,17234,0.169765623491908,0.0347803883228703,0.101596062379082,0.237935184604734,1.06454882977292e-06
CD300E,CMRF35-like molecule 2,Mental health,X29154.Anxiety or depression today,17234,0.0597841276232803,0.043338996563867,-0.025160305641899,0.14472856088846,0.167772910420389
CD300E,CMRF35-like molecule 2,Mental health,X29166.Frequency of confiding in someone close,16811,-0.0794742726183635,0.0339647324560151,-0.146045148232153,-0.012903397004574,0.0193002571097654
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17181,0.0199520868105375,0.00685929406468288,0.00650787044375905,0.0333963031773159,0.00363322688859254
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17181,-0.0140340846244753,0.00688850510228757,-0.0275355546249589,-0.000532614623991635,0.0416333560262208
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17181,-0.0210130585331006,0.00859340571080131,-0.0378561337262712,-0.00416998333993003,0.0144849981234652
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17181,0.0143727505271306,0.00926942400911727,-0.00379532053073925,0.0325408215850005,0.121026828658256
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17181,-0.0563684270304301,0.0150378529134639,-0.0858426187408193,-0.0268942353200409,0.000178524263770522
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17181,-0.00512237980091349,0.00709089075966533,-0.0190205256898575,0.00877576608803056,0.47006533415296
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17178,0.0120752131859378,0.00772308822046668,-0.0030620397261769,0.0272124660980525,0.117948457860735
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17178,-0.0190669425148922,0.0112866836856775,-0.0411888425388201,0.00305495750903563,0.0911742138958596
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17178,0.0185156184141625,0.0174799606195683,-0.0157451044001913,0.0527763412285164,0.289501623412651
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17178,0.0274858056194604,0.0156122837859444,-0.00311427060099064,0.0580858818399115,0.0783367513050099
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17178,-0.0571388440207996,0.023290570383536,-0.10278836197253,-0.011489326069069,0.0141649462725194
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17178,-0.0195887808958829,0.0110930278887682,-0.0413311155578686,0.00215355376610279,0.0774364084395164
CD300E,CMRF35-like molecule 2,Mental health,X29171.Frequency of feeling 'in tune' with people,16889,-0.119957039927317,0.0420299688215827,-0.202335778817619,-0.0375783010370143,0.00432137459070869
CD300E,CMRF35-like molecule 2,Mental health,X29172.Freuency of feeling that lacks companionship,17109,0.103507447421983,0.0383351580973665,0.0283705375511451,0.178644357292822,0.00693940073730221
CD300E,CMRF35-like molecule 2,Mental health,X29173.Frequency of feeling left out,17021,0.0713007262346363,0.0399676203622613,-0.00703580967539591,0.149637262144669,0.0744476232463506
CD300E,CMRF35-like molecule 2,Mental health,X29174.Frequency of feeling isolated from others,17087,0.0616952507304523,0.0412827777903196,-0.0192189937385741,0.142609495199479,0.1350752362834
CD300E,CMRF35-like molecule 2,Mental health,X29175.Tendency to bounce back quickly after hard times,17212,-0.0423800314714698,0.0341454617688527,-0.109305136538421,0.0245450735954814,0.214563037642723
CD300E,CMRF35-like molecule 2,Mental health,X29176.Ability to make it through stressful events,17212,0.0541131257214093,0.033007163877974,-0.0105809154794198,0.118807166922238,0.101140826805666
CD300E,CMRF35-like molecule 2,Mental health,X29177.Quick recovery from stressful events,17212,-0.0482264374890218,0.0337894243947577,-0.114453709302747,0.0180008343247033,0.153521899681443
CD300E,CMRF35-like molecule 2,Mental health,X29178.Hard to snap back when something bad happens,17212,0.0437356131120301,0.0331133837727288,-0.0211666190825183,0.108637845306578,0.186591118178018
CD300E,CMRF35-like molecule 2,Mental health,X29179.Comes through difficult times with little trouble,17212,-0.00503379207140798,0.03368745505124,-0.0710612039718383,0.0609936198290223,0.881219005553458
CD300E,CMRF35-like molecule 2,Mental health,X29180.Tendency to take a long time to get over setbacks,17212,0.0323930775544868,0.0334698686460908,-0.0332078649918512,0.0979940201008248,0.333143867021321
CD300E,CMRF35-like molecule 2,Mental health,X29181.General happiness,17113,0.0448623594042065,0.0348308205435867,-0.0234060488612233,0.113130767669636,0.197760773263787
CD300E,CMRF35-like molecule 2,Mental health,X29182.Belief that own life is meaningful,16920,-0.0331183025088791,0.0346696707735406,-0.101070857225019,0.0348342522072605,0.339463496053698
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11501,-0.0103773970236049,0.037162156941297,-0.0832152246285471,0.0624604305813372,0.78006079631629
CD300E,CMRF35-like molecule 2,Health and medical history,X2946.Father's age,11302,-0.010189053107532,0.00619358660627434,-0.0223284828558297,0.00195037664076574,0.0999775738864773
CD300E,CMRF35-like molecule 2,Health and medical history,X2966.Age high blood pressure diagnosed,12922,-0.0355730468895175,0.00549280218431266,-0.0463389391707703,-0.0248071546082647,9.74046344248409e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50084,0.058676788384698,0.00212508145276944,0.0545116287372698,0.0628419480321261,1.44139792126238e-166
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50085,0.00418075103780983,0.00239070193641625,-0.000505024757566032,0.00886652683318569,0.0803395729463303
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30020.Haemoglobin concentration,50085,-0.0376999798632059,0.00255269300707794,-0.0427032581570787,-0.0326967015693331,2.9608227591007e-49
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30030.Haematocrit percentage,50085,-0.022819712404389,0.00249752264522101,-0.0277148567890222,-0.0179245680197558,6.65724262700628e-20
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30040.Mean corpuscular volume,50085,-0.0353158072796351,0.00210630800284402,-0.0394441709652093,-0.0311874435940608,6.35448956288536e-63
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50084,-0.0473493231127162,0.00210850315353181,-0.0514819892936385,-0.0432166569317938,3.93405713098481e-111
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50084,-0.0333156210364105,0.00206295108934603,-0.0373590051715287,-0.0292722369012923,1.61023998952669e-58
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50085,0.0542060612581403,0.00205133459074414,0.0501854454602818,0.0582266770559988,7.99256996572662e-153
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30080.Platelet count,50085,0.0138516053742511,0.00211106227134777,0.00971392332240951,0.0179892874260928,5.38092108823051e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30090.Platelet crit,50085,0.0273596167699168,0.00215514816282586,0.0231355263707781,0.0315837071690555,7.18480731952016e-37
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50085,0.0173052061019865,0.00202610369847097,0.0133340428529834,0.0212763693509896,1.36595169793408e-17
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30110.Platelet distribution width,50085,0.00623244336223466,0.00205100137526728,0.0022124806667108,0.0102524060577585,0.00237698609493857
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30120.Lymphocyte count,50008,-0.0157656863787493,0.00210644348117493,-0.0198943156018521,-0.0116370571556464,7.29929240955693e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30130.Monocyte count,50008,0.118135021067038,0.00205794127677158,0.114101456164566,0.122168585969511,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30140.Neutrophill count,50008,0.0552469494422181,0.00210216046374996,0.0511267149332682,0.0593671839511681,3.38239985516553e-151
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30150.Eosinophill count,50008,0.0484816766992382,0.00204702836153179,0.0444695011106359,0.0524938522878405,2.53102952247404e-123
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30160.Basophill count,50008,0.15862830100592,0.0201265700445934,0.119180223718517,0.198076378293323,3.29877678228727e-15
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30170.Nucleated red blood cell count,50008,0.198846678214488,0.0903721961530265,0.0217171737545559,0.37597618267442,0.0277895977503504
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30180.Lymphocyte percentage,50009,-0.065466532393287,0.0020531125838251,-0.0694906330575841,-0.0614424317289898,6.8140337267284e-221
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30190.Monocyte percentage,50009,0.0868540474979616,0.00206416202221691,0.0828082899344165,0.0908998050615068,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30200.Neutrophill percentage,50009,0.0256174144827943,0.00204963202643608,0.0216001357109796,0.029634693254609,8.60112907909411e-36
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30210.Eosinophill percentage,50009,0.0292060508712069,0.0020328617756297,0.0252216417909726,0.0331904599514411,1.03365506137847e-46
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30220.Basophill percentage,50009,0.00725811798832882,0.00202748659452257,0.00328424426306457,0.0112319917135931,0.000344103904846742
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50007,0.201636686816279,0.0904388389627419,0.0243765624493045,0.378896811183253,0.0257826579326839
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30240.Reticulocyte percentage,49209,0.01687570500253,0.0021876049358216,0.0125879993283197,0.0211634106767403,1.2398994847613e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30250.Reticulocyte count,49209,0.0172319651431191,0.00223518983334864,0.0128509930697558,0.0216129372164824,1.28778984079626e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30260.Mean reticulocyte volume,49209,0.00614810216219966,0.00208535248714553,0.00206081128739443,0.0102353930370049,0.00319747651354174
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30270.Mean sphered cell volume,49209,-0.0221862055430533,0.00210137931497553,-0.0263049090004053,-0.0180675020857012,4.97810895192396e-26
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30280.Immature reticulocyte fraction,49209,0.0273038947326871,0.00218303532638428,0.0230251454929739,0.0315826439724003,7.72119540794051e-36
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49209,0.0249181330725338,0.00223209823526438,0.0205432205314156,0.029293045613652,6.66133367743882e-29
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30300.High light scatter reticulocyte count,49209,0.0253095259858348,0.00226657876169398,0.0208670316129147,0.029752020358755,6.45134548878185e-29
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30500.Microalbumin in urine,16264,0.0757112327511408,0.00391818030770429,0.0680315993480403,0.0833908661542412,2.87417768644155e-82
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50190,0.0271019766304161,0.00220303209598544,0.0227840337222846,0.0314199195385475,9.90127901086319e-35
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30520.Potassium in urine,50091,-0.00810592517226264,0.00205566852347429,-0.0121350354782723,-0.00407681486625302,8.05087338673231e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30530.Sodium in urine,50073,-0.0220522419818991,0.00214709969650111,-0.0262605573870413,-0.0178439265767569,1.01052760008957e-24
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30600.Albumin,45130,-0.0885047640573989,0.00217505766620793,-0.0927678770831665,-0.0842416510316314,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30610.Alkaline phosphatase,49253,0.0857749510658419,0.0020913552847962,0.0816758947076414,0.0898740074240425,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30620.Alanine aminotransferase,49247,0.00280352553881267,0.00224876502976756,-0.00160405391953176,0.00721110499715709,0.212515052465165
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30630.Apolipoprotein A,44854,-0.0714705550344156,0.0024037995013208,-0.0761820020570044,-0.0667591080118268,2.18555782027201e-192
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30640.Apolipoprotein B,48987,-0.00610910787398702,0.00205696211443064,-0.0101407536182711,-0.00207746212970297,0.00297976926280785
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30650.Aspartate aminotransferase,49101,0.0255947122755086,0.00213399821504692,0.0214120757740166,0.0297773487770006,4.26105359167568e-33
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30660.Direct bilirubin,41806,-0.00190424638001007,0.00231937772796534,-0.00645022672682214,0.00264173396680201,0.411641799594987
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30670.Urea,49232,0.0674459223952289,0.00215340627825728,0.0632252460898447,0.0716665987006132,3.07790505237935e-213
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30680.Calcium,45128,-0.0192990235112667,0.00214759968785348,-0.0235083188994595,-0.0150897281230739,2.65272439502763e-19
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30690.Cholesterol,49264,-0.0232428634673924,0.0020854790294415,-0.0273304023650978,-0.0191553245696871,8.19189298377067e-29
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30700.Creatinine,49244,0.15223017448493,0.00242858048180516,0.147470156740591,0.156990192229268,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30710.C-reactive protein,49115,0.164019099009565,0.00217852101090335,0.159749197828194,0.168289000190935,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30720.Cystatin C,49266,0.280089541232334,0.00205210151790746,0.276067422257236,0.284111660207433,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30730.Gamma glutamyltransferase,49243,0.0184273333937853,0.00228847656033693,0.0139419193355249,0.0229127474520457,8.31078667849836e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30740.Glucose,45076,-0.0178564724959532,0.00220397046631318,-0.0221762546099271,-0.0135366903819794,5.54295396362213e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48981,0.0193489180504324,0.00222569239024779,0.0149865609655467,0.023711275135318,3.62306379273418e-18
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30760.HDL cholesterol,45101,-0.079982727207925,0.00250516671302357,-0.0848928539654512,-0.0750726004503988,3.31397551972135e-221
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30770.IGF-1,49008,-0.0289512340934273,0.00214904534393491,-0.0331633629675397,-0.0247391052193148,2.72017296657306e-41
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30780.LDL direct,49153,-0.0121399394912433,0.00205991360875455,-0.0161773701644022,-0.00810250881808436,3.80740070979988e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30790.Lipoprotein A,39374,0.00951668084757231,0.00229109646459923,0.00502613177695783,0.0140072299181868,3.27735418126558e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30810.Phosphate,45027,0.0127167989776134,0.00222279503538872,0.00836012070825152,0.0170734772469753,1.06515606986186e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30830.SHBG,44709,0.00466583302509656,0.00255686555202826,-0.000345623456878829,0.00967728950707195,0.0680340637632749
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30840.Total bilirubin,49066,-0.0165965901691544,0.0021874782604088,-0.0208840475595556,-0.0123091327787531,3.3293639285726e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30850.Testosterone,44502,-0.0149976173329154,0.00355470552252164,-0.0219648401570578,-0.00803039450877298,2.45777194562399e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30860.Total protein,45094,0.0111536178700033,0.00218163382933081,0.00687761556451492,0.0154296201754917,3.19208917867707e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30870.Triglycerides,49225,0.0401021497581868,0.00223581121714341,0.0357199597725857,0.0444843397437879,1.04020407385743e-71
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30880.Urate,49195,0.0972744170001422,0.00254095579779895,0.0922941436364563,0.102254690363828,1.66880540738855e-308
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30890.Vitamin D,47032,-0.0157190066888349,0.00232515643480668,-0.0202763133010559,-0.0111617000766138,1.39206224810365e-11
CD300E,CMRF35-like molecule 2,Physical measures,X3137.Number of measurements made,46819,0.0121575296812251,0.0237675415448846,-0.0344268517467486,0.0587419111091989,0.608990672166678
CD300E,CMRF35-like molecule 2,Physical measures,X3143.Ankle spacing width,29291,0.0141560536624621,0.00368301361405594,0.00693734697891248,0.0213747603460118,0.000121495602047128
CD300E,CMRF35-like molecule 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29289,-0.00927110808346735,0.00283576545146727,-0.0148292083683432,-0.00371300779859151,0.00107919480703307
CD300E,CMRF35-like molecule 2,Physical measures,X3146.Speed of sound through heel,29291,-0.0167009710464435,0.00273828281634409,-0.0220680053664779,-0.0113339367264091,1.08024011357325e-09
CD300E,CMRF35-like molecule 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29291,-0.0144141569029828,0.00276746551436817,-0.0198383893111444,-0.00898992449482116,1.91730051518426e-07
CD300E,CMRF35-like molecule 2,Physical measures,X3148.Heel bone mineral density (BMD),29269,-0.0145428193610648,0.00277052220791774,-0.0199730428885836,-0.00911259583354601,1.53888223275216e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X3526.Mother's age at death,30796,-0.0107413065155168,0.00276082302651734,-0.0161525196474907,-0.00533009338354278,0.00010019970631972
CD300E,CMRF35-like molecule 2,Health and medical history,X3581.Age at menopause (last menstrual period),15904,-0.0206453192653958,0.00366976656765093,-0.0278380617379916,-0.0134525767928,1.8777938131821e-08
CD300E,CMRF35-like molecule 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10188,0.00558668015036516,0.00458556498359781,-0.00340102721748656,0.0145743875182169,0.223131089185953
CD300E,CMRF35-like molecule 2,Physical measures,X4100.Ankle spacing width (left),16616,0.0112860271544284,0.00483900994234102,0.00180156766744,0.0207704866414168,0.019696758864759
CD300E,CMRF35-like molecule 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16612,-0.0114378673605364,0.00372052636508155,-0.0187300990360962,-0.00414563568497655,0.00211367546097126
CD300E,CMRF35-like molecule 2,Physical measures,X4103.Speed of sound through heel (left),16616,-0.0234162954729462,0.00359749869544893,-0.0304673929160261,-0.0163651980298663,7.77946741210186e-11
CD300E,CMRF35-like molecule 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16616,-0.0198050232954934,0.00363544547737744,-0.0269304964311532,-0.0126795501598337,5.1734805146912e-08
CD300E,CMRF35-like molecule 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16603,-0.0195006056204641,0.0036409062883692,-0.0266367819456677,-0.0123644292952605,8.62300497186691e-08
CD300E,CMRF35-like molecule 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16616,-0.0198033869587686,0.00363545253682483,-0.0269288739309453,-0.012677899986592,5.18686921410164e-08
CD300E,CMRF35-like molecule 2,Physical measures,X4119.Ankle spacing width (right),16611,0.0105774455414689,0.0047535979114129,0.00126039363509959,0.0198944974478382,0.0260848800519232
CD300E,CMRF35-like molecule 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16610,-0.0134553848989472,0.00372888572892824,-0.0207640009276466,-0.00614676887024788,0.000308973455066209
CD300E,CMRF35-like molecule 2,Physical measures,X4122.Speed of sound through heel (right),16611,-0.0255510914928503,0.00359691345630386,-0.0326010418672059,-0.0185011411184948,1.26466816576859e-12
CD300E,CMRF35-like molecule 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16611,-0.0217216293085104,0.00363748857682665,-0.0288511069190907,-0.0145921516979302,2.39728110067262e-09
CD300E,CMRF35-like molecule 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16596,-0.0218830327156491,0.00364328365682344,-0.0290238686830231,-0.0147421967482752,1.93644774006904e-09
CD300E,CMRF35-like molecule 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16611,-0.0217197506215777,0.00363749281411299,-0.0288492365372392,-0.0145902647059162,2.40496958180282e-09
CD300E,CMRF35-like molecule 2,Physical measures,X4194.Pulse rate,17257,0.0221652497782256,0.00347665194154401,0.0153510119727993,0.0289794875836519,1.87049617160148e-10
CD300E,CMRF35-like molecule 2,Physical measures,X4195.Pulse wave reflection index,17257,-0.0073144534889602,0.00356826347037847,-0.014308249890902,-0.000320657087018388,0.0403928323037003
CD300E,CMRF35-like molecule 2,Physical measures,X4196.Pulse wave peak to peak time,17246,-0.00861533299280884,0.00355315286820436,-0.0155795126144894,-0.0016511533711283,0.0153312159984033
CD300E,CMRF35-like molecule 2,Physical measures,X4198.Position of the pulse wave peak,17257,0.00680951150203341,0.00358723941648554,-0.00022147775427824,0.0138405007583451,0.0576785806035973
CD300E,CMRF35-like molecule 2,Physical measures,X4199.Position of pulse wave notch,17257,0.0154896509010147,0.00347642575401318,0.00867585642314881,0.0223034453788805,8.41755281425359e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,17257,0.0101044341045046,0.00360705918114799,0.00303459810945452,0.0171742700995546,0.00509547822856007
CD300E,CMRF35-like molecule 2,Physical measures,X4269.Number of triplets attempted (left),16930,0.087231029681055,0.0993682326059245,-0.107530706226557,0.281992765588667,0.380034181333876
CD300E,CMRF35-like molecule 2,Physical measures,X4270.Volume level set by participant (left),16750,0.0393680985575161,0.0315461410593407,-0.0224623379187916,0.101198535033824,0.212065765058244
CD300E,CMRF35-like molecule 2,Physical measures,X4276.Number of triplets attempted (right),16935,-0.007756398752366,0.0954153386117444,-0.194770462431385,0.179257664926653,0.935211572934933
CD300E,CMRF35-like molecule 2,Physical measures,X4277.Volume level set by participant (right),16738,0.0836766894490099,0.0315224296009065,0.0218927274312331,0.145460651466787,0.00794982454106419
CD300E,CMRF35-like molecule 2,Cognitive function,X4288.Time to answer,17295,-0.0011693060175692,0.00402351149682773,-0.00905538855135155,0.00671677651621314,0.7713467601393
CD300E,CMRF35-like molecule 2,Cognitive function,X4290.Duration screen displayed,17295,0.0148925490151907,0.00367026298526364,0.00769883356407394,0.0220862644663074,4.979228068186e-05
CD300E,CMRF35-like molecule 2,Physical measures,X46.Hand grip strength (left),51506,-0.061639355167147,0.00288351338914514,-0.0672910414098715,-0.0559876689244225,6.08731017409955e-101
CD300E,CMRF35-like molecule 2,Physical measures,X47.Hand grip strength (right),51512,-0.0610372724756054,0.00286327447907793,-0.0666492904545982,-0.0554252544966127,2.13496398692862e-100
CD300E,CMRF35-like molecule 2,Physical measures,X48.Waist circumference,51656,0.0671357103679691,0.00446979798877454,0.0583749063099711,0.0758965144259672,6.97358668428196e-51
CD300E,CMRF35-like molecule 2,Health and medical history,X4803.Tinnitus,16980,0.0725278349486178,0.0366925183961626,0.000610498892139086,0.144445171005097,0.0480987070867678
CD300E,CMRF35-like molecule 2,Working and living environment,X4825.Noisy workplace,17200,0.102735225295466,0.041083139048381,0.0222122727606396,0.183258177830293,0.0124052251983662
CD300E,CMRF35-like molecule 2,Working and living environment,X4836.Loud music exposure frequency,17094,0.0738779090781938,0.0539137165353386,-0.0317929753310697,0.179548793487457,0.170611613045203
CD300E,CMRF35-like molecule 2,Physical measures,X49.Hip circumference,51648,0.0185643733940711,0.00358486976777478,0.0115380286492326,0.0255907181389097,2.24472403865467e-07
CD300E,CMRF35-like molecule 2,Physical measures,X50.Standing height,51604,0.0153191354843656,0.00284738005727848,0.00973827057209981,0.0209000003966314,7.47757768500542e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X5057.Number of older siblings,15183,-0.0010365632079387,0.0335489440967803,-0.0667924936376281,0.0647193672217507,0.975352053713141
CD300E,CMRF35-like molecule 2,Physical measures,X51.Seated height,51370,0.00340928348540212,0.00264681917053669,-0.00177848208884978,0.00859704905965403,0.197728042946733
CD300E,CMRF35-like molecule 2,Eye measures,X5181.Ever had eye surgery,11637,0.256658939454162,0.0741115357159496,0.111400329450901,0.401917549457423,0.000535825131368434
CD300E,CMRF35-like molecule 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11607,0.00835535762931112,0.0042280784667657,6.83238344503512e-05,0.0166423914241719,0.04816037859491
CD300E,CMRF35-like molecule 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11605,0.0073345028020452,0.00426438241664895,-0.00102368673458673,0.0156926923386771,0.0854691507084576
CD300E,CMRF35-like molecule 2,Eye measures,X5190.Duration at which refractometer first shown (right),11478,0.00544535315590628,0.0042768734484024,-0.00293731880296242,0.013828025114775,0.202969755150589
CD300E,CMRF35-like molecule 2,Eye measures,X5193.Duration at which refractometer first shown (left),11475,0.00646496165539809,0.004296825173718,-0.00195681568508919,0.0148867389958854,0.132456986876778
CD300E,CMRF35-like molecule 2,Eye measures,"X5199.logMAR, initial (right)",11566,0.00663608525899788,0.0400474487707534,-0.0718569143316788,0.0851290848496746,0.868391563720499
CD300E,CMRF35-like molecule 2,Eye measures,X5200.Final number of letters displayed (right),11566,0.079287020967032,0.269882602857865,-0.449682880634383,0.608256922568447,0.768928721087414
CD300E,CMRF35-like molecule 2,Eye measures,"X5201.logMAR, final (right)",11456,0.005645438655363,0.0043101277219963,-0.00280241167974975,0.0140932889904758,0.19028718058876
CD300E,CMRF35-like molecule 2,Eye measures,X5202.Number of rounds to result (right),11566,-0.0469947313292049,0.037612754141744,-0.120715729447023,0.0267262667886133,0.211530964701087
CD300E,CMRF35-like molecule 2,Eye measures,"X5206.logMAR, initial (left)",11560,0.0290181678641641,0.0399767794654051,-0.0493363198880299,0.107372655616358,0.467929764092139
CD300E,CMRF35-like molecule 2,Eye measures,X5207.Final number of letters displayed (left),11560,0.0567324609710108,0.240215540388778,-0.414089998190994,0.527554920133015,0.813302503014791
CD300E,CMRF35-like molecule 2,Eye measures,"X5208.logMAR, final (left)",11450,0.00488668974368447,0.00429261065457357,-0.00352682713927973,0.0133002066266487,0.254979113478065
CD300E,CMRF35-like molecule 2,Eye measures,X5209.Number of rounds to result (left),11554,0.00699205859692832,0.0377980209238024,-0.0670920624137244,0.081076179607581,0.853244226983943
CD300E,CMRF35-like molecule 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11063,-0.0230269984112525,0.00424856139887327,-0.0313541787530441,-0.0146998180694609,6.08680932715406e-08
CD300E,CMRF35-like molecule 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11063,-0.0255042966830536,0.00422231560979566,-0.0337800352782531,-0.0172285580878541,1.58723169883717e-09
CD300E,CMRF35-like molecule 2,Eye measures,X5256.Corneal hysteresis (right),11063,0.00202893330920528,0.0042928895463289,-0.00638513020159937,0.0104429968200099,0.636489016679145
CD300E,CMRF35-like molecule 2,Eye measures,X5257.Corneal resistance factor (right),11063,-0.0126881793022171,0.00426196258596982,-0.021041625970718,-0.00433473263371627,0.00291644474575396
CD300E,CMRF35-like molecule 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11032,-0.0222086379053094,0.00425734811788603,-0.030553040216366,-0.0138642355942528,1.85602890907356e-07
CD300E,CMRF35-like molecule 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11032,-0.0228789292849653,0.00421731487014193,-0.0311448664304435,-0.0146129921394871,5.91808764510821e-08
CD300E,CMRF35-like molecule 2,Eye measures,X5264.Corneal hysteresis (left),11032,0.00423530488123141,0.00430819649384263,-0.00420876024670014,0.012679370009163,0.325589302141466
CD300E,CMRF35-like molecule 2,Eye measures,X5265.Corneal resistance factor (left),11032,-0.00971749964171129,0.00426132254849954,-0.0180696918367704,-0.0013653074466522,0.0226032703034694
CD300E,CMRF35-like molecule 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11559,0.127007804816737,0.180941030191309,-0.227636614358228,0.481652223991702,0.482737426778172
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51492,0.0570526676216015,0.011568823739367,0.0343777730924423,0.0797275621507607,8.18175588442369e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51492,0.0328249905849479,0.0126092367229599,0.00811088660794652,0.0575390945619492,0.00923711799718465
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51492,0.0304895907386634,0.0120458087289225,0.00687980562997532,0.0540993758473514,0.011372298434284
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51492,-0.0133041023032384,0.00515290251072408,-0.0234037912242576,-0.00320441338221917,0.0098295184344226
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51492,-0.00100658179784273,0.00474094557456254,-0.0102988351239853,0.00828567152829986,0.831860828307263
CD300E,CMRF35-like molecule 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23272,-0.0172778750337731,0.0061345076265693,-0.029301509981849,-0.00525424008569729,0.00485900791243279
CD300E,CMRF35-like molecule 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23272,-0.0386613753198662,0.0166673319874706,-0.0713293460153085,-0.00599340462442392,0.0203716862394794
CD300E,CMRF35-like molecule 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23272,-0.0110224762281836,0.0119138512662306,-0.0343736247099956,0.0123286722536284,0.354881041009184
CD300E,CMRF35-like molecule 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23272,0.0119072341791627,0.0072621114116178,-0.00232650418760821,0.0261409725459336,0.10109397135519
CD300E,CMRF35-like molecule 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51652,-0.00287396205730777,0.00794374925159626,-0.0184437105904364,0.0126957864758209,0.717511102947903
CD300E,CMRF35-like molecule 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51652,0.0291866795169987,0.01024056230083,0.00911517740737191,0.0492581816266255,0.00437220756900483
CD300E,CMRF35-like molecule 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51652,-0.00891623161927214,0.0078521541082359,-0.0243064536714145,0.00647399043287023,0.256165252378351
CD300E,CMRF35-like molecule 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51652,-0.0249524893788527,0.0129164734299295,-0.0502687773015144,0.000363798543809052,0.0533853969642585
CD300E,CMRF35-like molecule 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51652,0.0275155644422904,0.0317011616208313,-0.0346187123345388,0.0896498412191197,0.385416392398347
CD300E,CMRF35-like molecule 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51652,0.0509800496662947,0.0218031202215735,0.00824593403201064,0.0937141653005787,0.019380685975633
CD300E,CMRF35-like molecule 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51652,0.0480512013095645,0.0343891404267072,-0.0193515139267816,0.115453916545911,0.162335887969368
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51491,0.0108463147843054,0.00658930653373026,-0.00206872602180596,0.0237613555904167,0.0997599835452689
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51491,0.0429641715871757,0.0112605666102695,0.0208934610310475,0.0650348821433038,0.000136091662540274
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51491,0.00830222656014305,0.00590847912747534,-0.00327839252970862,0.0198828456499947,0.159986380656892
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51491,0.0552353490533555,0.00989929585347527,0.035832729180544,0.0746379689261671,2.42107536087569e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51491,0.0302303496042384,0.009825794541012,0.0109717923038548,0.0494889069046219,0.00209463725734789
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51491,0.0777548452875073,0.0055138567993341,0.0669476859608125,0.0885620046142021,4.49763013713141e-45
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,16040,0.0781579262592117,0.0144912737957877,0.0497550296194677,0.106560822898956,7.00984658514842e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,16040,0.0271556272188299,0.0124690507296578,0.00271628778870057,0.0515949666489592,0.0294323046514343
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,16040,0.128392322469458,0.0171927013462839,0.0946946278307414,0.162090017108174,8.57133464642831e-14
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,16040,-0.00154032502901515,0.013760752809905,-0.0285114005364289,0.0254307504783986,0.910875473151316
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51435,0.0508762725685515,0.0167143808769392,0.0181160860497507,0.0836364590873524,0.00233680027271466
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51435,0.0426715856206611,0.0249925776756353,-0.00631386662358399,0.0916570378649062,0.0877592780077645
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51435,0.257853868103812,0.0444253933963786,0.17078009704691,0.344927639160714,6.50527800797408e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51435,0.0255750709630956,0.0428079749011687,-0.058328559843195,0.109478701769386,0.550218243116454
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51435,0.0151922895987665,0.0145355223179045,-0.0132973341443264,0.0436819133418593,0.295943033115013
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51435,0.0165099515908651,0.0193895351429649,-0.0214935372893462,0.0545134404710763,0.394502432348239
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51435,0.0227106207929966,0.00897703837141658,0.00511562558502007,0.040305616000973,0.0114138717782255
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16668,0.149410994496662,0.0144374617157625,0.121113569533768,0.177708419459557,5.04409055657948e-25
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16668,0.129147619705382,0.0156205605807052,0.0985313209671996,0.159763918443564,1.46642454324292e-16
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16668,0.137437431348728,0.0211006136491157,0.0960802285964615,0.178794634100995,7.55556929598403e-11
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16668,0.012042065198833,0.0074462580333975,-0.00255260054662615,0.0266367309442921,0.105854730401007
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23417,0.00980386253800716,0.00711791823538482,-0.00414725720334709,0.0237549822793614,0.168417328909124
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23417,-0.0531927053683886,0.00693419484964641,-0.0667837272736956,-0.0396016834630816,1.7720248085428e-14
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23417,0.0167700674757121,0.00634900523288658,0.00432601721925444,0.0292141177321698,0.00826265301188188
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23418,0.0415416791697269,0.0150907716811022,0.0119637666747666,0.0711195916646872,0.00591358702988912
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23418,0.0566881300413635,0.00899207836053018,0.0390636564547243,0.0743126036280026,2.94800139512312e-10
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23418,0.0160685513996394,0.0121823951375457,-0.00780894306995005,0.039946045869229,0.187182780005278
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51491,-0.0492731596146382,0.01377539517817,-0.0762729341638514,-0.0222733850654251,0.000348016763656111
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51491,-0.0049029753535058,0.00970239255618892,-0.0239196647636361,0.0141137140566245,0.613324510803533
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51491,0.0575517494343677,0.0267377527964055,0.00514575395341288,0.109957744915323,0.0313663465738928
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51491,-0.00732213474839835,0.00993999199325945,-0.0268045190551869,0.0121602495583902,0.461348390262782
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51491,-0.0427206201801138,0.0113386444922877,-0.0649443633849978,-0.0204968769752298,0.000164941513424329
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51491,0.110846900386192,0.0130257211576313,0.0853164869172347,0.136377313855149,1.78775597124158e-17
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51491,0.0176858574230969,0.00429112071878433,0.00927526081427964,0.0260964540319142,3.77000880560361e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10032,0.0864811827872097,0.0128844498948729,0.0612276609932587,0.111734704581161,2.02286113990218e-11
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10032,0.0907268683690766,0.0160435219753055,0.0592815652974779,0.122172171440675,1.60074311447033e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10032,-0.0833756773772325,0.011399877409748,-0.105719437100339,-0.0610319176541264,2.79715393775489e-13
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10032,0.00729439903411707,0.0102356332163967,-0.0127674420700206,0.0273562401382547,0.476080471628168
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51728,0.0159337201906688,0.00502475899973002,0.00608519255119793,0.0257822478301396,0.0015198198435876
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51728,0.0220251455162352,0.0144882439541112,-0.00637181263382278,0.0504221036662932,0.128464801125075
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51728,0.0136700811318296,0.00469994248612132,0.00445819385903182,0.0228819684046274,0.00363247916465419
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51728,0.0123481662637383,0.00454587502056456,0.0034382512234318,0.0212580813040449,0.00660289738728553
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51728,0.0443324250476809,0.00703406648328029,0.0305456547404515,0.0581191953549103,2.95176206298064e-10
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51728,0.0249426354396161,0.0062826145496488,0.0126287109223045,0.0372565599569278,7.19382043484082e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51728,0.0167027648622105,0.0048905411857272,0.00711730413818516,0.0262882255862358,0.00063755957964534
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51728,0.181110331969397,0.0143383715068368,0.153007123815997,0.209213540122797,1.60980240599013e-36
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35793,-0.0429690070628234,0.00488574350945733,-0.0525450643413597,-0.033392949784287,1.49607426311604e-18
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35793,0.00436095403412758,0.00510765844874277,-0.00565005652540826,0.0143719645936634,0.393217706018868
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35793,0.0296731022933359,0.00575789445057606,0.0183876291702069,0.040958575416465,2.57074815716981e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35794,-0.02543056796791,0.00789110626372991,-0.0408971362448206,-0.00996399969099932,0.00127107791231854
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35794,-0.00271688309055401,0.00516492990520786,-0.0128401457047614,0.0074063795236534,0.598873984673188
CD300E,CMRF35-like molecule 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51249,-0.012806641058339,0.00505215542768254,-0.0227088656965968,-0.00290441642008123,0.0112513227666601
CD300E,CMRF35-like molecule 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51249,-0.0260439909444857,0.00401887011170245,-0.0339209763634225,-0.0181670055255489,9.22914171357018e-11
CD300E,CMRF35-like molecule 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51249,0.00842601783333744,0.00445878763034106,-0.000313205922131035,0.0171652415888059,0.0587963260242116
CD300E,CMRF35-like molecule 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51249,-0.0535172722818377,0.00806077763853853,-0.0693163964533732,-0.0377181481103022,3.18486261609441e-11
CD300E,CMRF35-like molecule 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51284,-0.0562743768342478,0.00443408884205036,-0.0649651909646665,-0.0475835627038291,7.50829119020012e-37
CD300E,CMRF35-like molecule 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51284,-0.046490569885654,0.00692641134865969,-0.060066336129027,-0.032914803642281,1.9387197085008e-11
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51491,-0.0607751259332424,0.00437823603076112,-0.0693564685535342,-0.0521937833129506,9.87797341007816e-44
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51491,-0.0573719071681041,0.00518680943477654,-0.0675380536602661,-0.0472057606759421,2.08496250811996e-28
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51491,0.0165714083214982,0.00782429346957537,0.00123579312113048,0.0319070235218659,0.0341846666480955
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51491,-0.048658086988403,0.00992691148654906,-0.0681148335020391,-0.0292013404747668,9.533140980263e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51491,0.0375668647181402,0.0108158995101364,0.0163677016782728,0.0587660277580075,0.000514522440607595
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51491,-0.0682669402262549,0.0128947664771057,-0.093540682521382,-0.0429931979311278,1.20054648920444e-07
CD300E,CMRF35-like molecule 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29291,-0.0144123724252901,0.00276746617233777,-0.0198366061230722,-0.00898813872750811,1.92397987846763e-07
CD300E,CMRF35-like molecule 2,Physical activities,X864.Number of days or week walked 10+ minutes,50613,-0.131538935925402,0.0182860646103031,-0.167379622561596,-0.0956982492892079,6.40720999383761e-13
CD300E,CMRF35-like molecule 2,Physical activities,X874.Duration of walks,43854,-0.00615629811915895,0.00213054188275893,-0.0103321602093665,-0.00198043602895146,0.0038598800169751
CD300E,CMRF35-like molecule 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48932,-0.182581229072814,0.0178245227360482,-0.217517293635468,-0.147645164510159,1.34363849851966e-24
CD300E,CMRF35-like molecule 2,Physical activities,X894.Duration of moderate activity,37881,-0.0299309772523832,0.0217849028296444,-0.0726293867984863,0.01276743229372,0.169470896345756
CD300E,CMRF35-like molecule 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10805,-0.0250869103224667,0.00442113298577875,-0.0337523309745931,-0.0164214896703404,1.42830993252676e-08
CD300E,CMRF35-like molecule 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48840,-0.273834557849428,0.0184154118242882,-0.309928765025032,-0.237740350673823,6.65375011590601e-50
CD300E,CMRF35-like molecule 2,Physical activities,X914.Duration of vigorous activity,27353,-0.00198452047057779,0.00260805166014891,-0.00709630172446964,0.00312726078331407,0.44671100214687
